Neurology · Full case

Parkinson's Disease

NICE NG71DVLA

NICE NG712022: Parkinson's disease diagnosis is by a specialist — GP refers within 6 weeks; do NOT initiate Parkinson's medication without specialist advice; annual primary care review mandated

Drug-inducedMost common mimic: metoclopramide, prochlorperazine, haloperidol, risperidone cause dopamine-blockade parkinsonism — review ALL medications at every presentation; stop offending drug; features may persist 6–12 months

UK Brain BankBradykinesia PLUS rigidity OR resting tremor OR postural instability — at least two of the triad. NOT essential tremor (action/postural, bilateral, no rigidity, no bradykinesia)

ICD warningDopamine agonists (ropinirole, pramipexole, rotigotine): impulse control disorders in up to 17% — gambling, hypersexuality, binge eating, compulsive shopping; MANDATORY warning before prescribing; screen at EVERY review

Levodopa NBMParkinson's patient who cannot swallow cannot absorb oral levodopa → acute-off state → akinetic crisis; subcutaneous apomorphine or NG-tube medication essential; this is a medical emergency that GP and ward staff frequently miss

Metoclopramide ⛔ABSOLUTELY CONTRAINDICATED in Parkinson's disease — dopamine antagonist causes acute severe motor deterioration; use domperidone (poor CNS penetration) or ondansetron for nausea/vomiting instead

Non-motor prodromeREM sleep behaviour disorder, constipation, hyposmia, and depression may precede motor features by 10–20 years — retrospective identification helps confirm diagnosis; non-motor features are often the dominant disability

30–40%Parkinson's disease dementia (PDD) develops in 30–40% within 10 years; cognitive screening at every annual review; MMSE or MoCA; rivastigmine only licensed cholinesterase inhibitor for PDD

📋 Clinical Stem — Parkinson's Disease

A 67-year-old retired teacher presenting with a 9-month history of right-hand tremor, stiffness, and slowing — currently prescribed metoclopramide for nausea

Ian Hopkinson, 67, a retired secondary school teacher, is brought in by his wife Mary. Over the past 9 months he has developed a tremor in his right hand — worst at rest, better when he reaches for things. He has also noticed increasing stiffness in his right arm and that he is generally slower getting dressed and doing things around the house. His wife has noticed he no longer swings his right arm when walking and that his gait has become shuffling. Three months ago the GP prescribed metoclopramide for nausea after a course of antibiotics; the nausea has resolved but the metoclopramide has been continued. Ian still drives — he collects his grandchildren from school weekly and uses the car independently. He has not told anyone how frightened he is about what this might mean.

This stem has four interlocking challenges: (1) recognising the clinical triad of Parkinson's disease (resting tremor, rigidity, bradykinesia); (2) identifying that the metoclopramide must be stopped — it is contraindicated in Parkinson's and may be causing or worsening the features; (3) managing the DVLA issue — Ian drives and must be counselled; (4) addressing the patient's hidden fear about the diagnosis and its implications. The metoclopramide question is a classic prescribing safety scenario — candidates who don't connect it to the parkinsonism miss a critical safety issue.

Scenario A — Established Parkinson's: dopamine agonist side effects 58-year-old man on ropinirole 8mg TDS for 3 years, wife phones concerned about recent gambling — he has spent £4,000 online in 3 months. Impulse control disorder (ICD): dopamine agonist-induced; prevalence up to 17%; requires urgent specialist review; immediate dose reduction or switch to levodopa. Screen for other ICDs: hypersexuality, binge eating, compulsive shopping. Never dismiss spouse/carer concerns. Document and refer urgently.

Scenario B — Levodopa wearing-off 72-year-old woman on Sinemet 100/25 TDS for 5 years, now experiencing predictable worsening of motor symptoms 3–4 hours after each dose (wearing-off). Wearing-off: dopaminergic neuron loss means levodopa duration shortens. Options (specialist decision): increase dose frequency; add COMT inhibitor (entacapone) to extend levodopa; add MAO-B inhibitor; modified-release levodopa at night. GP role: recognise the pattern, not alter doses unilaterally — refer to specialist for adjustment.

Scenario C — Parkinson's and swallowing difficulty (NBM crisis) 78-year-old with advanced Parkinson's admitted to hospital with pneumonia, now NBM. Hospital team have stopped his Sinemet. Levodopa NBM rule: stopping levodopa in a patient with advanced Parkinson's causes acute-off state — rigidity, akinesia, potentially neuroleptic malignant syndrome-like picture. Management: NG tube medications; subcutaneous apomorphine infusion; contact neurology/specialist Parkinson's nurse urgently. This is a common and preventable hospital harm.

Scenario D — Differential: drug-induced vs idiopathic Parkinson's 70-year-old woman on prochlorperazine 5mg TDS (prescribed 8 years ago for "dizziness") presenting with tremor and rigidity. Prochlorperazine: dopamine antagonist — causes drug-induced parkinsonism. Stop prochlorperazine; most commonly used long-term for vestibular symptoms but evidence does not support this beyond 2 weeks; features may take 6–12 months to resolve after stopping; refer neurology to confirm no underlying idiopathic Parkinson's; prochlorperazine is a very common cause of drug-induced parkinsonism in elderly women.

Scenario E — Parkinson's disease dementia (PDD) 74-year-old man with Parkinson's for 8 years, wife reports memory problems, vivid nightmares, and seeing things. PDD: develops in 30–40% within 10 years; visual hallucinations (characteristically formed, non-threatening); REM sleep behaviour disorder; cognitive fluctuations. Management: cholinesterase inhibitor — rivastigmine is the only licensed option for PDD (donepezil is not licensed for PDD). AVOID antipsychotics unless absolutely essential — use only quetiapine or clozapine if necessary (typical antipsychotics cause fatal Parkinson's deterioration).

Key variables to adapt for Age at presentation (young-onset <50 — genetic testing; dopamine agonist preferred to delay levodopa); dominant symptom (tremor-dominant vs akinetic-rigid variant); presence of drug-induced parkinsonism (medication review is always step one); red flags for Parkinson's plus syndromes (PSP, MSA, DLB, CBD — poor levodopa response; early falls; early autonomic features; early dementia); carer burden and patient's insight; driving safety; DVLA status; non-motor symptom burden (often dominates quality of life).

Steps:

Step 1

History Taking — Open Question · Tremor Characterisation · Drug Review · Non-Motor Features · ICE

▲collapse

The Parkinson's history has three equally important components: motor symptom characterisation (triad of tremor, rigidity, bradykinesia), comprehensive medication review (drug-induced parkinsonism is the most common mimic and must be excluded before diagnosis), and non-motor feature screening (often the most disabling component and frequently missed). NICE NG71 is clear: the GP does not diagnose Parkinson's disease — that is a specialist's role. The GP's task is to build the comprehensive clinical picture that enables an accurate and urgent referral, and to identify immediate prescribing safety issues (metoclopramide, prochlorperazine, DVLA) that must be addressed today regardless of the diagnosis.

🎓 SCA framing — connect Ian's fear before the clinical interrogation

"It is good that you came in today, Ian — and good that you brought Mary along. Before I go through the questions, I want to check in with you: this must feel quite worrying. Is there a particular concern that has been weighing on you most? Sometimes people have read something online or have a family member with a similar condition and are carrying a fear they have not said out loud yet."

Ian has not told anyone how frightened he is. His fear is likely: "Is this Parkinson's disease?" and "Will I lose my driving licence?" The SCA marks are won by surfacing these hidden concerns early, not by efficiently completing the clinical checklist while the patient sits with unspoken terror.

1A — Open question then motor feature characterisation

Question	Why it matters	Changes what?
🟢 OPEN QUESTION"Tell me in your own words about the tremor and the changes you have noticed — starting from when you first noticed something was different."	The clinical history of Parkinson's disease is diagnostic before the examination. The open narrative reveals the most clinically significant features: when did it start; which side first; was the onset gradual; what makes the tremor better or worse (resting vs action tremor — critical differential); is there stiffness or slowing accompanying it. Parkinson's disease characteristically has a unilateral onset with gradual progression — a symmetrical onset or rapid progression are red flags for a Parkinson's plus syndrome or drug-induced cause. Ian's right-sided onset with 9-month gradual progression is consistent with idiopathic Parkinson's — but the metoclopramide means this cannot be assumed.In SCA: a candidate who asks "have you got a tremor?" and "is it worse when moving?" has gathered the minimum. A candidate who asks "when did you first notice something was different; which side; is it there when your hand is at rest or when you reach for things; what makes it better or worse; has anything else changed beyond the tremor" has gathered a diagnostically meaningful history.	Resting tremor → Parkinson's; action/postural tremor → essential tremorTemporal pattern; unilateral onset; rate of progression → referral urgency
Tremor characterisation"Is the tremor there when your hand is resting in your lap — or does it appear when you reach out to pick something up? What makes it better or worse?"	The tremor type is the key differentiating feature between Parkinson's disease and the two most common mimics. Parkinson's resting tremor: present when the limb is at rest; characteristically "pill-rolling" (4–6 Hz rotation of thumb against index finger); SUPPRESSED when the patient intentionally moves the limb; re-emerges after a few seconds on sustained posture. Essential tremor: action and postural tremor — worsened or only present during movement or sustained posture; absent at rest; bilateral; head/voice tremor common; family history positive in 50%; improved by alcohol. Drug-induced: may be mixed; typically symmetrical; association with dopamine-blocking medication.A common SCA trap: the examiner describes a patient who "shakes when trying to hold their cup" — this is an action/postural tremor, not a resting tremor. The correct response is to consider essential tremor, not Parkinson's. Resting tremor is specific for Parkinson's; action tremor is not. Never confuse them.	Resting tremor + suppressed on movement: Parkinson's. Action tremor: essential tremor or physiological. Mixed: drug-induced or PD with both typesEssential tremor: propranolol or primidone; NOT levodopa
Bradykinesia and daily function"Have you noticed that you are slower at everyday tasks — doing up buttons, handwriting, getting out of a chair? Has your handwriting changed?"	Bradykinesia is the central criterion for Parkinson's disease diagnosis per the UK Brain Bank criteria — it must be present for the diagnosis. Key manifestations in daily life: micrographia (progressively smaller handwriting — ask to see a sample or write a sentence); reduced facial expression (hypomimia); reduced arm swing when walking (Mary noticed this); difficulty with fine motor tasks; getting slower and more effortful with repetitive movements (fatiguing). Bradykinesia differentiates Parkinson's from pure essential tremor — essential tremor does not cause bradykinesia.Micrographia is pathognomonic — having the patient write a sentence in the consultation is both a clinical examination finding and a diagnostic test. Handwriting that starts normal-sized and progressively decreases in size across a line is highly specific for Parkinson's. "Does your handwriting start normal and then get smaller as you write across the page?" is a question that often gives an immediate diagnostic response.	Bradykinesia present → Parkinson's (required criterion). Absent → essential tremor, not Parkinson'sFunctional impact assessment: for referral letter; OT referral; driving assessment
Gait and balance"Has your walking changed — do people notice a shuffle? Do you feel unsteady? Have you fallen?"	Shuffling gait (reduced step length); festination (involuntary acceleration — feet cannot keep up with centre of gravity; high fall risk); reduced arm swing (Mary noticed this); turning difficulty (en-bloc turning — cannot turn smoothly, pivots in multiple steps); freezing episodes (sudden inability to initiate movement, especially doorways). Falls: Parkinson's falls are a major cause of morbidity; fall risk stratification is essential at every review. Early falls (within first year): red flag for Parkinson's plus syndrome (PSP — falls backwards from postural instability; CBD — alien limb, asymmetric).The question "have you had any falls?" is mandatory for all patients presenting with possible Parkinson's disease. Falls in the first year of symptom onset, before medication has been tried, are highly atypical for idiopathic Parkinson's and should raise suspicion for PSP or vascular parkinsonism. PSP is the most commonly missed Parkinson's plus syndrome in primary care.	Early falls: PSP red flag. Bilateral lower limb predominance: vascular parkinsonismFall risk → falls assessment; occupational therapy; home safety; DVLA
Medication review — metoclopramide"I want to look carefully at all the medications you are taking, because some common tablets can cause exactly the symptoms you are describing."	Drug-induced parkinsonism is the most important differential diagnosis to exclude and the most important prescribing safety issue. Dopamine-blocking drugs cause parkinsonism indistinguishable clinically from idiopathic Parkinson's disease. Common culprits: metoclopramide (prescribed for nausea, gastroparesis — extremely commonly the offending drug in primary care); prochlorperazine (prescribed for vertigo, dizziness, vomiting — often continued indefinitely without review); domperidone (weak dopamine antagonism; rarely causes significant parkinsonism at standard doses); antipsychotics (haloperidol, risperidone, chlorpromazine — typical more than atypical). In Ian's case: metoclopramide was prescribed 3 months ago — the timing is directly relevant. Drug-induced features may persist for 6–12 months after stopping the offending drug. The metoclopramide must be stopped today.Prochlorperazine (Stemetil) is the most commonly missed offending drug in elderly women presenting with parkinsonism. It is prescribed for "dizziness" or "vertigo" and continues for years without review. Any elderly patient with parkinsonism who is on prochlorperazine: stop it, wait 6–12 months, reassess. If features do not resolve: refer for specialist diagnosis to exclude underlying idiopathic Parkinson's.	Metoclopramide/prochlorperazine: stop immediately; drug-induced parkinsonismStop offending drug today. Do NOT start Parkinson's medication until drug-induced cause excluded by specialist. Antiemetic alternative: domperidone or ondansetron
Side of onset and progression"Did it start on one side first — or did it begin on both sides at the same time? Has it spread to the other side?"	Unilateral onset with gradual ipsilateral progression, then contralateral involvement is characteristic of idiopathic Parkinson's disease. Symmetrical onset is a red flag for drug-induced parkinsonism (bilateral because dopamine blockade is systemic) or Parkinson's plus syndromes. Rapid progression (full bilateral involvement within 1 year) is a red flag for PSP, CBD, or MSA. Ian has 9-month history of right-sided features — this is consistent with idiopathic Parkinson's but the metoclopramide complicates the picture until it is stopped and assessed.The asymmetric onset of idiopathic Parkinson's disease is one of the diagnostic criteria (supporting criterion in UK Brain Bank). A neurologist who notes bilateral symmetrical onset will be more sceptical about idiopathic Parkinson's and more likely to investigate for drug-induced cause or Parkinson's plus syndrome.	Unilateral onset → idiopathic PD. Symmetrical → drug-induced, PSP, or vascularOnset pattern documented in referral letter
DVLA — driving"I need to ask about driving. Are you still driving? The law requires us to discuss this at this appointment."	Parkinson's disease impairs driving through motor symptoms (tremor, rigidity, bradykinesia affecting steering and braking), cognitive effects (reduced reaction time, visuospatial impairment, divided attention), and medication effects (drowsiness from dopamine agonists; sudden-onset sleep — patients must be warned). DVLA requirement: patients with Parkinson's disease must notify the DVLA. Ability to continue driving is assessed case-by-case — the diagnosis does not automatically mean loss of licence, but DVLA notification is mandatory. GP must counsel, advise notification, and document. If patient has an accident after the GP knew of the diagnosis and did not counsel on DVLA: medico-legal liability.Dopamine agonist-induced sudden-onset sleep (narcolepsy-like sudden sleep episodes without warning) is a specific driving hazard — patients on dopamine agonists must be specifically warned about this and must not drive if they experience sudden-onset sleep episodes. This is not a generic drowsiness warning — it is a sudden, potentially fatal safety event.	DVLA notification mandatory; GP documents advice; sudden-onset sleep warning if dopamine agonist prescribedIan drives to collect grandchildren — practical impact; occupational safety; DVLA form

1B — Red flags suggesting Parkinson's plus syndrome, not idiopathic PD

🚨

Red Flags — features that indicate NOT idiopathic Parkinson's disease

Red flag	Suggests	Action
Early falls (within first 1–2 years of onset), especially backwards	PSP (Progressive Supranuclear Palsy): postural instability from the outset; retrocollis; vertical supranuclear gaze palsy (inability to look down voluntarily); axial > limb rigidity; poor levodopa response. PSP is the most commonly missed Parkinson's plus syndrome in primary care and is significantly more aggressive than idiopathic Parkinson's.	Urgent specialist referral; inform neurologist that early falls are present; PSP has poor prognosis and different management
Rapid progression to bilateral involvement within 1 year	Parkinson's plus syndromes (PSP, MSA, CBD) progress faster than idiopathic Parkinson's. MSA (Multiple System Atrophy): early autonomic failure (orthostatic hypotension, urinary incontinence, erectile dysfunction) + parkinsonism or cerebellar ataxia; poor levodopa response. Rapid progression also raises the possibility of secondary (structural) cause.	Urgent neurology; inform of rapid progression; MRI brain; DaTscan may be helpful
Early prominent autonomic failure (severe OH, urinary incontinence, erectile dysfunction)	MSA: autonomic failure is the cardinal distinguishing feature. In idiopathic Parkinson's, autonomic features occur but are typically later and milder. Severe orthostatic hypotension (BP drop >30mmHg systolic) in a patient with early parkinsonism strongly suggests MSA. Management differs completely from idiopathic Parkinson's.	Neurology urgently; lying/standing BP; MSA has median survival of 6–10 years from symptom onset
Early dementia (within first year of motor onset) with hallucinations	Dementia with Lewy Bodies (DLB): dementia before or concurrent with parkinsonism; characteristic fluctuating cognition; vivid visual hallucinations (formed, non-threatening, often people or animals); REM sleep behaviour disorder. Cholinesterase inhibitors (rivastigmine, donepezil) are the mainstay — NOT levodopa (causes worsening hallucinations). CRITICAL: antipsychotics cause severe, potentially fatal deterioration in DLB — the neuroleptic sensitivity reaction.	Urgent neurology; DaTscan; AVOID antipsychotics; rivastigmine for cognitive symptoms; inform specialist about DLB concern
Alien limb phenomenon, markedly asymmetric motor signs, limb apraxia	Corticobasal Degeneration (CBD): highly asymmetric parkinsonism; dystonia; limb apraxia; alien limb (affected limb acts independently); poor levodopa response. Rare but important differential — management and prognosis very different from idiopathic Parkinson's.	Neurology urgently; MRI brain; DaTscan; neuropsychological assessment
Symmetrical onset; no response to levodopa after adequate trial	Vascular parkinsonism: lower limb dominant ("lower body parkinsonism"); no tremor; stepwise progression; prominent gait freezing and falls; vascular risk factors and imaging changes; poor or absent levodopa response. Drug-induced parkinsonism: symmetric (bilateral); on a dopamine-blocking drug; resolves over months after stopping. Idiopathic Parkinson's disease always shows at least 30% improvement on adequate levodopa trial.	Medication review; stop dopamine blockers; MRI brain (white matter changes); vascular risk factor management; neurology

🛡️

Safeguarding Considerations in Parkinson's Disease

🚗 DVLA and Road Safety

DVLA notification is mandatory — Parkinson's disease is a prescribed condition under the Road Traffic Act
Parkinson's disease does not automatically mean loss of licence — DVLA assesses case-by-case; most patients with mild, well-controlled disease can continue driving with annual DVLA review
GP duty: advise patient to notify DVLA; document this advice; if patient refuses and continues driving and GP believes they are not safe: GP can breach confidentiality and inform DVLA directly
Dopamine agonist sudden-onset sleep: mandatory warning to NEVER drive if sudden-onset sleep episodes have occurred

🏠 Falls and Home Safety

Falls are the leading cause of serious injury in Parkinson's disease — 60% of patients fall annually; Parkinson's disease falls have a higher injury rate than population falls
Home safety assessment: occupational therapy referral for home hazard assessment, grab rails, raised toilet seat, bath aids, stair assessment
Hip fracture risk: osteoporosis screening; calcium and vitamin D supplementation; bisphosphonate if indicated; fall prevention exercise (Parkinson's disease-specific physiotherapy)
Parkinson's UK helpline: 0808 800 0303 — specialist Parkinson's nurses available

👨‍👩‍👧 Carer Burden and Wellbeing

Mary (wife): carer stress is universal in Parkinson's disease and is frequently unacknowledged. Ask specifically: "How are you managing, Mary? Are you getting enough support?"
Carer assessment: GP can arrange Social Services carer assessment; carer's allowance; respite care; Parkinson's UK Carer Support Group
Cognitive and behavioural symptoms (ICD, dementia, psychosis) are more distressing for carers than motor symptoms
ICD (impulse control disorder) disclosure: sometimes the carer is the one who discloses; always create a private opportunity for the carer to speak

💊 Prescribing Safety

Metoclopramide: stop immediately — contraindicated in Parkinson's disease; acute dopamine blockade can cause dramatic motor deterioration
Prochlorperazine (Stemetil): contraindicated — review all patients in the practice with this combination
Antipsychotics: if psychosis requires treatment, ONLY quetiapine or clozapine; typical antipsychotics and most atypical agents cause severe deterioration and can be fatal in Parkinson's
DLB: antipsychotics cause fatal neuroleptic sensitivity reaction — absolute contraindication

Immediate actions today: Stop metoclopramide — document reason and alternative antiemetic prescribed (domperidone or ondansetron). DVLA counselling — document date and patient response. Carer wellbeing check — offer Mary a separate appointment or Social Services carer assessment. Fall risk screen — TIMED UP AND GO test; home assessment referral if indicated.

1C — Non-motor features and systemic history

🧠 Non-motor features — often dominate quality of life

Feature	Why ask	Management impact
Sleep — REM sleep behaviour disorder (RBD)	Acting out dreams during sleep (punching, kicking, shouting — patients often injure themselves or their partner). RBD precedes motor Parkinson's by up to 20 years — one of the strongest prodromal markers. In established Parkinson's, RBD is common and distressing. Ask Ian specifically; ask Mary (she may be the one who has noticed).	RBD: clonazepam 0.5mg nocte (evidence-based) or melatonin 3–12mg; bedroom safety (padding, removing sharp objects); warning to partner. Excessive daytime somnolence: drowsy driving risk; DVLA implications; check dopamine agonist dose.
Constipation and autonomic symptoms	Constipation precedes motor Parkinson's by years and is extremely common in established disease (reduced gut motility from Lewy bodies in enteric nervous system). Orthostatic hypotension: postural dizziness on standing (autonomic involvement); lying/standing BP at every review. Urinary urgency/frequency. Excessive sweating. Erectile dysfunction.	Constipation: regular laxatives (osmotic); adequate fluid intake; dietary fibre; macrogol. Orthostatic hypotension: fludrocortisone or midodrine; compression stockings; bed-head tilt. BP check lying/standing at every visit.
Mood — depression and anxiety	Depression affects 35–45% of patients with Parkinson's disease — bidirectional neurobiological relationship. Not just a response to diagnosis — dopaminergic and serotonergic pathways are affected by Lewy body deposition. Often underrecognised and undertreated. Anxiety (panic attacks, social anxiety) also common. PHQ-9 at every annual review.	PHQ-9 ≥10: SSRIs (sertraline or citalopram) — evidence-based in Parkinson's; avoid MAO-B inhibitors (rasagiline, selegiline) + SSRIs (serotonin syndrome risk). Referral to Parkinson's specialist nurse or clinical psychology. Anxiety: CBT evidence-based; buspirone considered.
Cognition — from MCI to dementia	Mild cognitive impairment (MCI) is present in up to 30% of newly diagnosed patients; Parkinson's disease dementia (PDD) develops in 30–40% within 10 years. Visuospatial deficits are often the earliest cognitive changes (driving implications). MoCA is more sensitive than MMSE for PDD (tests frontosubcortical function, visuospatial).	MoCA at every annual review. MoCA <26: specialist review; rivastigmine (only licensed cholinesterase inhibitor for PDD). Driving: cognitive impairment adds to driving risk; DVLA specialist driving assessment. Carer support: dementia-specific resources.
Hyposmia — loss of smell	Anosmia or hyposmia precedes motor Parkinson's by years and is present in over 90% of patients at diagnosis. Retrospective identification ("when did you last notice a change in your sense of smell?") can help temporal profiling. Not currently a routine clinical test but useful diagnostic context.	Loss of smell: safety counselling (cannot smell gas or smoke — fit smoke alarms; gas detector; do not leave cooking unattended). Dietary implications (cannot smell food — may reduce appetite; nutrition assessment).
Pain	Pain affects up to 85% of patients with Parkinson's disease at some point — it is vastly underrecognised. Types: musculoskeletal (rigidity-related); dystonic pain (cramping, often in foot or hand — can be early feature or off-period pain); radicular (from postural changes); central pain (burning, poorly localised). Levodopa often improves pain during "on" periods.	Off-period dystonic pain: levodopa optimisation by specialist. Musculoskeletal: physiotherapy; analgesia. Central pain: tricyclic antidepressants; duloxetine. Assess at every review — pain is a quality of life issue that responds to Parkinson's-specific treatment.

💊 Drug history · Social history

Factor	Why it matters	Impact
Complete medication list	Drug-induced parkinsonism: metoclopramide, prochlorperazine, haloperidol, risperidone, flupentixol, chlopromazine, domperidone (rarely), cinnarizine, flunarizine. Any dopamine antagonist is potentially causative. Review systematically at every presentation. Duration and timing: when did the medication start relative to symptom onset?	Stop metoclopramide today. Alternative antiemetic: domperidone 10mg TDS (safer in Parkinson's; poor CNS penetration) or ondansetron 4–8mg. Document reason for stopping. Monitor for improvement over 6–12 months after stopping offending drug.
Family history	Most Parkinson's disease is sporadic. However, young-onset Parkinson's (<50 years) has a stronger genetic component: LRRK2 mutations (most common); PARK2/Parkin mutations; SNCA duplications. First-degree relative with young-onset Parkinson's raises the probability of a genetic form and may warrant genetic counselling and testing.	Young-onset + family history: genetic counselling referral; neurology for genetic testing. Implications for siblings and children.
Occupation and social function	Ian is a retired teacher — the relevant social function is: driving (grandchildren); independent mobility; self-care; hobbies. Fine motor tasks (writing, computing, cooking) affected by bradykinesia. Retirement status reduces occupational hazard but social participation (driving) is central. Exercise history: Parkinson's disease exercise is the most effective non-pharmacological intervention — ask specifically about activity.	DVLA counselling: Ian drives. Exercise prescription: specific Parkinson's exercise (Nordic walking, boxing, cycling — evidence for neuroplasticity benefit and motor improvement). Physiotherapy referral for gait and balance.
Carer and home support	Mary has been managing Ian's increasing needs for 9 months. She is an unpaid carer. Her wellbeing is as important as Ian's clinical management. Carer burnout leads to earlier institutionalisation of the patient. Social Services carer assessment; carer's allowance eligibility; Parkinson's UK Carer Support line; respite care.	Carer assessment arranged. Mary's concerns heard separately. Parkinson's UK helpline provided. Social Services referral if carer support needs identified. Mental health support for Mary if indicated (GP record).

1D — ICE

💭 Ideas

"What do you think might be causing these symptoms, Ian — has a particular diagnosis crossed your mind?"

Ian almost certainly suspects Parkinson's disease — he has had 9 months to think about it, and the symptoms are characteristic. He may have a parent or friend with Parkinson's, shaping his illness model. Surfacing his own hypothesis allows the GP to calibrate the explanation and address any specific fears or misconceptions (e.g., "I have seen what late-stage Parkinson's looks like and I am terrified"). Eliciting the idea also avoids the jarring experience of the GP mentioning Parkinson's for the first time when the patient has been silently managing that fear for months.

😟 Concerns

"What is worrying you most about all of this — is it the diagnosis, your independence, your driving, or something else?"

Ian's hidden concerns are likely: (1) losing his driving licence — the weekly grandchildren trip is central to his identity and relationships; (2) the trajectory of the disease — "will I end up in a wheelchair?"; (3) being a burden on Mary. Identifying the dominant concern structures the consultation. Mary may have different concerns from Ian — she may be most worried about his safety falling, or about ICD if she has noticed behavioural changes. If both are present: ask each of them separately.

🎯 Expectations

"What were you hoping would happen at this appointment — a diagnosis, tests, medication, or just some clarity on what happens next?"

Ian may be expecting a diagnosis today, or may be hoping to be told it is something simpler (the metoclopramide, perhaps). Managing the expectation that the GP cannot diagnose Parkinson's disease — and why the specialist referral is genuinely necessary — avoids the patient feeling dismissed. "I am referring you urgently to a specialist, not because I do not have ideas about what this might be, but because the diagnosis requires a specialist assessment and we also need to sort out this medication question first."

1E — Psychosocial context

Parkinson's disease is not just a movement disorder — it is a condition that progressively threatens the central dimensions of a person's identity, independence, and relationships. For Ian: driving (independence; the grandchildren relationship); fine motor skills (the retired teacher who values literacy and writing); gait and balance (falling in public — humiliation and fear). Mary's experience as a carer begins at diagnosis and intensifies over time. The psychosocial intervention starts at the first appointment: surfacing the fears, naming the concerns, and framing the future with both honesty and hope.

🚗 Driving and Independence

Ian drives to collect his grandchildren weekly. Losing this capability is not a minor inconvenience — it affects a central relationship and is a profound marker of independence. DVLA notification is legally required, but the conversation must acknowledge the impact before repeating the legal requirement.

"I know the driving question matters enormously to you — it is not just practical, it is about being independent and staying connected to your family. I want to be honest with you: there are legal requirements I need to address. Parkinson's disease means you must notify the DVLA. But the diagnosis does not automatically mean you cannot drive — many people with Parkinson's continue driving safely for years with the right support."

🏥 Prognosis and the Fear of End-Stage Disease

Many patients with Parkinson's have seen a family member or friend with advanced disease and fear that this is their inevitable future. Accurate prognostic information is therapeutic: most people diagnosed today have a much better prognosis than 20 years ago, with medications allowing many years of good quality of life. The disease is highly variable — some people progress slowly over decades; others faster. Framing hope with honesty.

"I hear that you are frightened about what this might mean for the future. The honest answer is that it varies enormously between individuals. What I can tell you is that treatment has improved significantly, and many people with Parkinson's disease live well for many years. We are not there with the diagnosis yet, but I want you to know that this is not a straight road to helplessness."

👨‍👩‍👧 Mary's Experience as Carer

Mary has been quietly watching Ian change for 9 months. She may have researched online, may be frightened herself, and almost certainly has unspoken needs and concerns. She has brought Ian to this appointment — which itself suggests she has taken an active caring role. Her wellbeing is clinically important: carer burnout leads to patient harm. Creating a space for Mary to speak directly — and separately if needed — is clinical care, not social courtesy.

"Mary, I want to ask you directly — how are you managing? What is your day-to-day experience like, and are there ways we can support you? Carers often carry a great deal and we want to make sure you have the support you need too."

🎭 Loss of Identity and Role

Ian was a teacher — a person whose identity involved cognitive agility, standing at the front of a room, commanding language. Micrographia, bradykinesia, and cognitive changes threaten these dimensions of identity. Acknowledging what Parkinson's threatens (not just what it does clinically) creates a therapeutic alliance that makes every subsequent clinical conversation more productive.

"As a teacher, I imagine you are someone who values being sharp, being clear, being able to write and communicate. The symptoms you have described affect exactly the things that matter to people like you. I want to acknowledge that — and to say that managing Parkinson's well is partly about protecting exactly these things as long as possible."

💊 The Metoclopramide Question

Ian's challenge line — "could this be caused by the tablets you gave me for the nausea?" — is a prescribing safety moment. The GP prescribed the metoclopramide. The patient has made a connection. The GP must: (1) acknowledge the possibility seriously and openly; (2) not be defensive; (3) stop the metoclopramide immediately; (4) explain what happens next; (5) not over-promise that stopping it will definitely resolve the features.

"That is a really important question, Ian. You are right to make that connection — metoclopramide can cause exactly these kinds of symptoms by blocking dopamine in the brain. I am stopping it today. I want to be honest: it may not fully explain all of your symptoms, and we will need the specialist to assess you after you have been off it for a while. But stopping it is the right first step, and I am glad you raised it."

🧠 Cognitive Change and Future Planning

Cognitive changes in Parkinson's range from subtle executive dysfunction to full dementia (PDD). Early counselling about cognitive monitoring, driving implications of cognitive decline, and advance care planning while capacity is intact is compassionate and practically important. Not frightening — framing: "while things are well, it is worth thinking about preferences for the future."

"One thing I want to mention now, while you are well and we are at the beginning of this journey: over time, Parkinson's can sometimes affect memory and thinking for some people. We will monitor for that carefully. And it is often a good time, while everything is clear and you can make your own decisions, to think about what you might want in the future — things like a lasting power of attorney. I can help you think through that."

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases that score

"Ian, the medication you are on for nausea — metoclopramide — can actually cause the exact symptoms you are describing by blocking dopamine in the brain. I am stopping it today. It does not mean your symptoms will definitely go away, but it is the right first step, and the specialist will assess you after you have been off it for a while."

"I cannot diagnose Parkinson's disease today — that is a specialist's role. But what I can do is refer you urgently, stop the metoclopramide now, and give you and Mary the information you need."

"On driving — you need to notify the DVLA. The diagnosis of Parkinson's does not automatically stop you from driving, but you must notify them and they will assess you. Many people with early Parkinson's continue driving safely. I want to make sure we have that conversation properly today."

Deductions

Not stopping metoclopramide — it is contraindicated; stopping it today is the most important immediate clinical action
Diagnosing Parkinson's disease — specialist must confirm
Starting Parkinson's medication — specialist only
Not addressing DVLA — mandatory counselling and documentation
Ignoring Mary — carer wellbeing is part of the clinical assessment
Not asking about ICDs if discussing dopamine agonists

🔴 Red

Metoclopramide not stopped; levodopa started in GP; Parkinson's diagnosed; DVLA not mentioned; metoclopramide-parkinsonism link missed; non-motor features not explored; Mary ignored; ICD warning not given if dopamine agonist discussed

🟠 Amber

Metoclopramide stopped; neurology referral made; DVLA mentioned vaguely; ICE partial; non-motor features partially explored; Mary not specifically addressed; motor triad not fully characterised; red flags for Parkinson's plus not asked

🟢 Green

Metoclopramide stopped with explanation; specialist referral made; DVLA counselled and documented; ICE all three including Mary; non-motor features screened; motor triad characterised; red flags explored; Mary's wellbeing addressed; ICD warning if dopamine agonist discussed; advance care planning mentioned; closing question

Step 2

Triage — New Presentation · Established Parkinson's Crisis · End-of-Life

▲collapse

Parkinson's disease triage separates three very different clinical situations: new presentation requiring specialist diagnosis; acute clinical deterioration in established disease (medication crisis, infection, ICD emergency); and end-stage/palliative needs. The most dangerous triage errors are: failing to recognise that an acutely unwell patient with known Parkinson's who cannot swallow is at risk of an akinetic crisis from missed levodopa, and prescribing metoclopramide or prochlorperazine to a patient with Parkinson's disease.

🔴 Emergency

999 / A&E Now

Immediate action

Akinetic crisis — Parkinson's patient who cannot swallow levodopaStops absorbing levodopa → extreme rigidity; hyperpyrexia; rhabdomyolysis; death. NG tube medications or SC apomorphine infusion; specialist urgent. NEVER prescribe metoclopramide as antiemetic in this situation.
Neuroleptic malignant syndrome (NMS) or NMS-like reactionAfter antipsychotic given to Parkinson's patient; rigidity + hyperpyrexia + autonomic instability. Immediate admission; stop antipsychotic; dantrolene; ITU.
Sudden-onset sleep episode while drivingDopamine agonist side effect; patient may present after near-miss or RTC. Must stop driving immediately; refer neurology urgently.
Severe ICD with financial or personal harmGambling away life savings; dangerous sexual behaviour. Emergency psychiatry or neurology; family support; may require urgent AED dose reduction under specialist guidance.

🟠 Urgent

Within 1–6 Weeks

Specialist + GP

New suspected Parkinson's diseaseRefer specialist within 6 weeks (NICE NG71); stop dopamine-blocking drugs; full assessment before diagnosis
Suspected Parkinson's plus syndromeEarly falls; rapid progression; symmetrical onset; poor levodopa response → urgent neurology within 2 weeks
Wearing-off or dyskinesia developmentRefer neurology for medication adjustment; add COMT inhibitor or adjust levodopa schedule
ICD symptoms on dopamine agonistUrgent specialist review; dose reduction; patient and family counselling

🟢 Annual Review

GP-Led with Specialist Support

Parkinson's nurse + GP

Stable Parkinson's — annual reviewNICE NG71 mandates annual primary care review: motor function, non-motor symptoms, medication, falls, cognition (MoCA), mood (PHQ-9), DVLA, carer wellbeing, advance care planning
Parkinson's nurse specialist (PNS) review6-monthly or more frequently for complex cases; medication titration between specialist appointments; community liaison
Advance care planningBefore cognitive decline; preferred place of care; DNACPR; ADRT; LPA

🎓 SCA Checkpoint — Step 2Tasks

Triage rationale

"There is no emergency here today — but I want to act quickly. I am stopping the metoclopramide now and I am referring you to a specialist within the next few weeks. Before that, I want to do a brief examination today."

Deductions

Not recognising the metoclopramide as potentially causal and not stopping it urgently
Not referring to neurology — NICE NG71 mandates specialist diagnosis within 6 weeks

Step 3

Examination — Motor Triad · Rigidity · Bradykinesia · Gait

▲collapse

The GP examination of suspected Parkinson's disease should characterise the motor triad (tremor type and distribution, rigidity pattern, bradykinesia severity) and identify red flags suggesting Parkinson's plus syndromes. The examination findings do not establish the diagnosis — that is the specialist's role. But they provide critical information for the referral letter and may identify urgent features (falls, cognitive impairment) requiring immediate action.

Examination	What to find and why	Finding changes management	Changes?
Tremor — observe at rest and in action	Observe hands at rest in the patient's lap before they know you are looking at the tremor — resting tremor is suppressible and patients often unconsciously suppress it when asked to display it. Ask the patient to count backwards to distract attention. The resting tremor re-emerges after a few seconds on sustained posture ("re-emergent tremor"). Essential tremor: appears immediately on outstretched arms; no resting component; bilateral; head/voice involvement common. Pill-rolling tremor (4–6 Hz circular motion of thumb against index finger) is pathognomonic of Parkinson's.	Resting tremor + pill-rolling: Parkinson's. Action-only, bilateral: essential tremor (not Parkinson's). Symmetric resting tremor in patient on metoclopramide: drug-induced.	YES — diagnostic direction
Rigidity — passive limb movements	Passive flexion and extension of the wrist and elbow — feel for resistance throughout the range of movement. Lead pipe rigidity: uniform resistance throughout — Parkinson's. Cogwheel rigidity: ratchety interrupted resistance — lead pipe + superimposed tremor — pathognomonic of Parkinson's. Gegenhalten (paratonia): variable resistance — frontal lobe dysfunction. Spasticity: clasp-knife (high initial resistance then suddenly releases) — upper motor neurone. Froment's manoeuvre: ask patient to move the contralateral hand (wave, perform repetitive movements) while you passively move the ipsilateral wrist — unmasks subtle rigidity.	Lead pipe or cogwheel rigidity: supports Parkinson's. Absent rigidity: questions Parkinson's diagnosis. Asymmetric rigidity (right > left in Ian): consistent with idiopathic Parkinson's unilateral onset.	YES — documents triad
Bradykinesia — finger tapping and rapid alternating movements	Ask patient to tap thumb against index finger as fast and as wide as possible. In Parkinson's: progressive fatiguing — amplitude decreases and speed slows with repetition (decrement). Also test rapid pronation/supination of hands and foot tapping. Micrographia: ask patient to write a sentence — writing progressively smaller. The decrement on repetition is the key feature distinguishing Parkinson's bradykinesia from pure essential tremor (no decrement in ET).	Decrement on repetition: bradykinesia — supports Parkinson's (required criterion). Asymmetric (right > left): consistent with right-sided onset. No decrement: ET, not Parkinson's. Micrographia confirmed in consultation: document for referral letter.	YES — required criterion
Gait observation and Timed Up and Go (TUG)	Observe: step length (shortened in Parkinson's); arm swing (absent or reduced on affected side); turning (en-bloc — cannot pivot smoothly); festination (accelerating, short steps). TUG test: time from seated, stand, walk 3m, return, sit. >12 seconds: significant fall risk. Pull test (retropulsion): GP gently pulls patient backwards — Parkinson's: patient takes multiple steps back or falls; PSP: falls immediately with no protective steps (axial rigidity without compensatory stepping).	Festination/reduced arm swing: Parkinson's gait. TUG >12s: falls risk; OT/physio referral; home assessment. Immediate fall on pull test: PSP red flag; urgent neurology. Normal gait: reconsider diagnosis.	YES — fall risk + Parkinson's plus screen
Eye movements — vertical gaze, saccades	Vertical supranuclear gaze palsy (VSGP) — inability to look downward voluntarily (preserved oculocephalic reflex) — is pathognomonic of PSP. Ask patient to follow a moving finger up and down; then ask them to voluntarily look down to the floor without following a target. Slowed saccades on horizontal gaze: PSP and CBD. Normal eye movements do not exclude Parkinson's plus; abnormal eye movements are a red flag that changes management.	Impaired downward gaze: PSP — urgent neurology; fundamentally different prognosis and management. Normal: does not exclude PSP (may be early) but reduces probability.	YES — PSP red flag screen
Lying and standing blood pressure	Orthostatic hypotension (>20mmHg systolic fall on standing after 1 and 3 minutes): autonomic dysfunction — common in Parkinson's disease; severe early OH raises concern for MSA. Also identifies patients at high risk of falls (postural dizziness). Treatment implication: may need to adjust antihypertensives; consider fludrocortisone or midodrine. Document at every review.	OH >30mmHg systolic: MSA concern — urgent neurology. OH present: medication review (antihypertensives); fludrocortisone; compression stockings. Fall risk increased — falls assessment; OT.	YES — MSA screen + falls risk

🎓 SCA Checkpoint — Step 3Tasks

Examination rationale

"I want to examine your arms and hands, watch you walk, and check your blood pressure lying and standing. The examination helps me characterise what is happening and also checks for falls risk — which is important for your safety at home."

Deductions

Not performing lying/standing BP — falls risk and MSA screen both require this
Not including Mary in the consultation — her observations (shuffling gait, reduced arm swing) are clinically valuable

Step 4

Investigations — What GP Orders vs Specialist Arranges

▲collapse

NICE NG71 does not recommend routine blood tests or imaging for the diagnosis of Parkinson's disease in primary care — the diagnosis is clinical, made by a specialist. The GP's investigative role is limited to: excluding treatable mimics (thyroid dysfunction, structural lesion if atypical features), cognitive screening (MoCA), and annual monitoring in established disease. DaTscan (SPECT imaging of dopaminergic function) and MRI brain are specialist-arranged investigations for diagnostic uncertainty.

Investigation	Who orders / when	What result changes management
TFTs — thyroid function	GP orders. Hypothyroidism can cause slowness, bradykinesia-like picture, and depression — occasionally mistaken for Parkinson's. Hyperthyroidism: tremor (action, not resting), but worth checking to exclude. Should be included in the initial workup of any patient presenting with tremor or motor slowing before the specialist referral. Not diagnostic of Parkinson's but helps exclude a treatable alternative.	Hypothyroidism: treat — symptoms may resolve without Parkinson's medication. Normal TFTs: metabolic cause excluded; clinical picture more likely primary neurological.
FBC, U&E, LFTs, calcium	GP orders as baseline investigation of any patient with new neurological presentation. Anaemia (pallor mimicking reduced facial expression), hypercalcaemia (neuropsychiatric features), hepatic encephalopathy (tremor, confusion), hyponatraemia (confusion, falls). Not diagnostic of Parkinson's but screens for treatable comorbidities and provides baseline before AED initiation.	Abnormal results: treat underlying cause; may resolve parkinsonism features. Normal: baseline established; comorbidity screen complete.
MoCA (Montreal Cognitive Assessment)	GP or practice nurse. The MoCA is more sensitive than MMSE for the frontosubcortical and visuospatial deficits of Parkinson's. Score <26/30 suggests cognitive impairment warranting specialist assessment. In established Parkinson's: perform at every annual review to detect emerging PDD. If driving: cognitive impairment adds to driving hazard and DVLA implications (DVLA medical questionnaire; specialist driving assessment).	MoCA <26: specialist review; rivastigmine discussion; DVLA implications; carer support escalation. MoCA normal: document as baseline; repeat annually.
DaTscan (dopamine transporter scan) — specialist arranges	SPECT imaging using a radiolabelled ligand that binds dopamine transporters in the striatum. Normal DaTscan: excludes Parkinson's disease, DLB, PSP, CBD (all have dopaminergic deficits). Essential tremor, drug-induced parkinsonism, vascular parkinsonism: normal DaTscan. Positive DaTscan (reduced uptake): confirms nigrostriatal dopaminergic deficit — consistent with idiopathic Parkinson's or Parkinson's plus. Used when clinical diagnosis is uncertain. GP should NOT order this — specialist investigation with specific clinical indications.	Normal DaTscan: excludes Parkinson's disease, DLB; suggests drug-induced, vascular, or ET. Reduced DaTscan: confirms dopaminergic deficit — Parkinson's diagnosis supported (but does not distinguish idiopathic from Parkinson's plus).
MRI brain — specialist arranges	Not required for diagnosis of typical idiopathic Parkinson's disease. NICE NG71: MRI indicated for atypical features (early falls, rapid progression, young-onset, poor levodopa response, suspected vascular parkinsonism). Vascular parkinsonism: white matter changes on MRI; lacunar infarcts. PSP/CBD: brainstem and cortical atrophy on specific MRI sequences. Structural lesion causing secondary parkinsonism: tumour, normal pressure hydrocephalus, subdural haematoma. GP does not order unless red flag emergency features suggest structural lesion (headache, rapid onset, focal signs).	White matter disease: vascular parkinsonism; vascular risk factor management; no specific Parkinson's medication. Structural lesion: neurosurgery or oncology. Normal: supports idiopathic or genetic Parkinson's.

🎓 SCA Checkpoint — Step 4Tasks

Investigations

"I am going to do a brief cognitive test today — a standard test we use for anyone presenting with these kinds of symptoms. And I will check some blood tests including thyroid function. The specialist will arrange any brain scans or more specialised tests."

Deductions

Ordering DaTscan from primary care — specialist investigation with specific indications
Not doing a cognitive screen — MoCA is a routine part of the Parkinson's workup and has DVLA implications

Step 5

Diagnosis — Plain Language Explanation · Differential Diagnosis

▲collapse

The GP does not diagnose Parkinson's disease — but must give Ian and Mary an honest, accessible explanation of what is likely happening, why specialist confirmation is needed, and what the next steps involve. The metoclopramide complicates the picture: Ian must understand that the drug may be contributing, but that this does not necessarily mean stopping it will resolve everything.

🗣️ Explaining the clinical picture in plain language

"I want to be honest with you about what I am seeing and thinking — while being clear that only the specialist can confirm this. The tremor in your right hand, the stiffness, and the slowing are the three features that together make me think about Parkinson's disease. Parkinson's disease happens when the brain gradually produces less of a chemical called dopamine — and dopamine is the chemical the brain uses to make smooth, controlled movement possible. The medication you are on for nausea — metoclopramide — works by blocking dopamine in the body, which can produce very similar features. That is why stopping it today is so important. After you have been off it for a few months, the specialist will be able to assess you more clearly. What I cannot tell you today is whether all your symptoms are from the metoclopramide, from Parkinson's disease, or from both. That is exactly what the specialist is for."

💬 Addressing the most common concerns

"Does this mean I definitely have Parkinson's disease?"
"I cannot say yes or no to that today. What I can say is that the features you have are consistent with it, but there are other possibilities — including the metoclopramide — and only the specialist, with access to more detailed assessment and potentially specialised scans, can make that determination. I do not want to give you a diagnosis I cannot confirm."

"Will I end up in a wheelchair?"
"I understand why that fear is there. The truth is: Parkinson's disease varies enormously between people, and we cannot predict the course for any individual. What I can tell you is that treatment has improved significantly, that many people with Parkinson's disease live active lives for many years, and that we would manage this together with a specialist team."

A — Idiopathic Parkinson's Disease

Most likely (pending drug washout)

UK Brain Bank criteria: Bradykinesia + rigidity/resting tremor/postural instability. Unilateral onset; resting tremor; gradual progression; good levodopa response (≥30% improvement); levodopa-induced dyskinesias.

Ian: Right-sided resting tremor; arm swing reduction; shuffling gait; bradykinesia (slower at dressing, handwriting). 9-month gradual onset. Consistent — but metoclopramide must be excluded first.

B — Drug-Induced Parkinsonism

Active contributing factor

Metoclopramide (Ian's case)

Dopamine D2 antagonist; clinical features identical to idiopathic Parkinson's; typically symmetric; may unmask latent Parkinson's. Stop today; reassess after 6–12 months.

Prochlorperazine

Most common cause in elderly women (prescribed for "dizziness"); often long-term; stop and reassess.

Antipsychotics

Haloperidol, risperidone most common; review any long-term antipsychotic in patient with parkinsonism.

C — Parkinson's Plus (red flag features)

Must exclude — worse prognosis

PSP

Early falls (backwards); downgaze palsy; axial > limb; poor levodopa. Urgent neurology.

MSA

Early severe autonomic failure; cerebellar ataxia OR parkinsonism. Poor levodopa.

DLB

Early dementia; visual hallucinations; fluctuating cognition. Rivastigmine; AVOID antipsychotics.

Essential Tremor

Action/postural tremor; no rigidity; no bradykinesia. Propranolol or primidone.

🎓 SCA Checkpoint — Step 5TasksRelating to Others

Explaining the picture

"The metoclopramide is definitely part of the picture — it blocks dopamine and can produce exactly these symptoms. I am stopping it today. After you have been off it for a while, the specialist will assess you more clearly and tell us whether the symptoms are entirely from the medication or whether there is something more going on. I cannot give you a diagnosis today — but I want you to know that I am taking this seriously and acting on it."

Deductions

Telling Ian "it is definitely not Parkinson's because the metoclopramide explains everything" — cannot be concluded until drug washout is complete
Diagnosing Parkinson's — specialist must confirm

Step 6

Referral — Neurology / Geriatrics · DVLA · OT · Parkinson's Nurse

▲collapse

NICE NG71: every patient with suspected Parkinson's disease should be referred promptly to a specialist with expertise in movement disorders. The referral should be made even if drug-induced parkinsonism is possible — because the specialist must confirm whether drug-induced features fully explain the picture after washout, and because Parkinson's plus syndromes require specialist diagnostic assessment. The referral letter is clinically important: it provides the motor characterisation, medication history, timeline, and red flag information that enables the specialist to plan the most efficient diagnostic pathway.

Referral	Urgency	Include	What NOT to do
Neurology or geriatrics (movement disorders specialist)	Within 6 weeks (NICE NG71) — sooner if Parkinson's plus features	Motor symptom characterisation (tremor type, rigidity, bradykinesia severity, asymmetry, duration); gait and falls; red flag features (early falls, symmetrical onset, rapid progression, downgaze palsy, severe autonomic dysfunction); medication history (metoclopramide — stopped today; date stopped); cognitive screen result (MoCA); blood results; DVLA discussion outcome; patient and carer concerns; explicit question to specialist: "Please confirm diagnosis after metoclopramide washout and advise on Parkinson's medication and DVLA."	Do NOT initiate levodopa or dopamine agonist before specialist assessment. Do NOT diagnose Parkinson's on the referral letter (state "suspected Parkinson's disease"). Do NOT reassure patient that stopping metoclopramide will definitely resolve symptoms.
DVLA — patient must notify	Immediately on diagnosis	Parkinson's disease is a notifiable condition under the DVLA. Patient must notify DVLA (V1 medical questionnaire or gov.uk online). DVLA assesses fitness to drive individually — does not automatically revoke licence. May require specialist driving assessment. Dopamine agonists: sudden-onset sleep warning — patient must not drive if this occurs. GP documents DVLA discussion.	Do NOT advise patient to withhold diagnosis from DVLA. If patient drives unsafely and refuses to notify: GP may breach confidentiality and inform DVLA directly.
Physiotherapy	After specialist diagnosis confirmed	Parkinson's disease-specific physiotherapy: evidence for improvement in gait, balance, falls, exercise tolerance. LSVT BIG (Lee Silverman Voice Treatment — physical version): high-intensity amplitude training. Nordic walking; boxing; cycling — all evidence-based. Physiotherapist can provide falls risk assessment, cueing strategies (auditory, visual), exercise prescription.	Do NOT wait until symptoms are advanced before referring physiotherapy — early physiotherapy is evidence-based for neuroplasticity benefit (slowing progression) and functional maintenance.
Occupational therapy (OT) and Speech and Language Therapy (SALT)	After specialist diagnosis; OT urgently if falls present	OT: home safety assessment; assistive devices (grab rails, raised toilet seat, adapted cutlery); driving assessment; workplace adaptations. SALT: dysarthria; dysphagia (critical — aspiration pneumonia risk; modified diet if swallowing impaired). LSVT LOUD (voice): evidence-based for hypophonia (soft voice).	Dysphagia in Parkinson's: urgent SALT referral — aspiration pneumonia is the leading cause of death in advanced Parkinson's. Never dismiss swallowing difficulty in Parkinson's as "just the disease".

🎓 SCA Checkpoint — Step 6Tasks

Referral plan

"I am referring you today to a neurologist who specialises in movement disorders — that is the specialist for conditions like Parkinson's disease. The guideline says that should happen within 6 weeks. I am also stopping the metoclopramide today and prescribing you a safer antiemetic if you still need one. I need to talk about DVLA — that is a legal requirement."

Deductions

Starting levodopa before specialist assessment — specialist-only decision
Not referring to neurology — mandatory per NICE NG71
Not stopping metoclopramide today

Step 7

Management — Metoclopramide Stop · AEDs · ICD Warning · DVLA · Non-Motor · Carer · ACP

▲collapse

7A — Address expectations

🤝

Ian wants to know: "Is it Parkinson's? Will I lose my licence? Could the tablets have caused this?" — the GP can address two of these today

Acknowledge the fear — it is real and legitimate

Ian has lived with this fear for 9 months without saying it out loud. Mary has been watching. Both need to feel that the GP sees them as people, not as a set of clinical criteria. The clinical management can wait 30 seconds for this acknowledgement.

"I can hear that this has been frightening, and I am glad you came in. What you have noticed over these months is real, and we are going to address it properly. Let me go through what I am doing today and what happens next."

What the GP can do today

Stop metoclopramide immediately — explain why. Prescribe alternative antiemetic. Arrange specialist referral within 6 weeks. DVLA counselling. Cognitive screening. Carer wellbeing check for Mary. Safety net for red flags.

"Today I am stopping the metoclopramide — it is the most important thing I can do right now. I am also referring you to a specialist urgently, doing a cognitive test, and talking through the driving rules. That is a lot for one appointment, but I want to make sure all of it is done properly."

What cannot happen today

The GP cannot diagnose Parkinson's disease and cannot start Parkinson's medication. Explain why honestly: "The diagnosis requires the specialist, and it would be wrong to start treatment before we know whether the symptoms are from the medication or from Parkinson's itself."

"I am not able to give you a firm diagnosis today — and I will not start Parkinson's medication until the specialist has confirmed what is happening. I know that might be frustrating when you want answers. But it would not be fair to start treatment that might not be the right treatment."

7B — Priority goals

Management priorities (today)

Stop metoclopramide immediately — prescribe alternative antiemetic (domperidone or ondansetron)Neurology referral within 6 weeks (NICE NG71) DVLA counselling — notify DVLA; ability to drive assessed individuallyMoCA cognitive screen Mary's wellbeing assessed — carer support discussionTFTs + FBC + metabolic screen Falls risk assessment (TUG) — OT referral if indicatedSafety-netting: red flags; advance information about ICD if dopamine agonist likely

Immediate prescribing actions

STOP: Metoclopramide — contraindicated in Parkinson's disease (confirmed or suspected). Document in notes: "Metoclopramide stopped [date] due to suspected drug-induced parkinsonism; alternative antiemetic prescribed."

PRESCRIBE: Domperidone 10mg TDS if nausea continues (preferred antiemetic in Parkinson's — poor CNS penetration). If domperidone not appropriate: ondansetron 4mg up to TDS. Do NOT prescribe prochlorperazine as alternative.

7C — Non-medication management and lifestyle

🏃

Exercise — the most effective non-pharmacological intervention

Neuroplasticity benefit; functional maintenance

Evidence base

Exercise in Parkinson's disease has the strongest non-pharmacological evidence: reduces falls; improves gait speed; improves quality of life; and emerging evidence suggests neuroplasticity (slowing of neurodegeneration). Specific modalities with evidence: Nordic walking; dance; boxing (Parkinson's specific); cycling; LSVT BIG; aquatic therapy. High-intensity exercise (not gentle mobility) is the evidence-based prescription. Parkinson's UK: exercise groups and physiotherapy links.

Prescription

At least 2.5 hours moderate-intensity exercise per week; include balance, strength, and aerobic components; Parkinson's-specific physiotherapy referral; Parkinson's UK exercise classes. For Ian: Nordic walking may be appropriate given his mobility — low impact, provides rhythmic auditory cuing which specifically helps Parkinson's gait.

Exercise is the most evidence-based non-pharmacological intervention in Parkinson's disease

🚗

DVLA Driving Notification

Mandatory; individual assessment; not automatic revocation

The rules

Parkinson's disease is a prescribed medical condition under the Road Traffic Act — patients must notify the DVLA. The DVLA does not automatically revoke the licence: they assess fitness to drive individually, taking specialist medical reports into account. Many patients with mild, well-controlled early Parkinson's continue driving safely with annual DVLA review. Dopamine agonists: sudden-onset sleep — specific warning; patient must not drive if this side effect occurs. Cognitive impairment: adds driving hazard; specialist driving assessment may be required.

For Ian

Must notify DVLA at gov.uk (V1 form or online). GP documents: date of advice; Ian's understanding; action plan. If Ian refuses and continues driving unsafely: GP may breach confidentiality and notify DVLA directly. Practical: specialist driving assessment available through mobility centres for patients who want to continue driving safely.

Notification mandatory; most early Parkinson's patients can continue driving with DVLA review

🏠

Falls Prevention and Home Safety

60% annual fall rate; hip fracture prevention

Home assessment

OT home assessment: remove trip hazards (rugs, trailing cables, poor lighting); install grab rails (bathroom, toilet); raised toilet seat; bath board or wet room; bed rails; intercom. Footwear: firm-soled, non-slip. Festination (walking faster and faster): auditory cuing (rhythmic beat from music or metronome) or visual cuing (floor markings, laser) — Parkinson's physiotherapy teaches these strategies.

Fall response plan

Personal emergency response system (community alarm) for when Ian is alone. Community falls service referral. Calcium and vitamin D supplementation. FRAX osteoporosis risk assessment. Hip protector pads if very high fall risk. Lie-detector technology for delayed rises after falls (prolonged lying = serious injury risk).

Falls prevention programme reduces hospitalisation and prolongs independent living

🗣️

Communication and Nutrition

SALT referral; dysphagia prevention; LSVT LOUD

Voice and speech

Hypophonia (soft, monotone voice) affects communication and social participation. LSVT LOUD is the evidence-based speech therapy programme for Parkinson's — improves vocal loudness and clarity. Refer SALT early — before communication breaks down. Masked face (hypomimia) can cause misinterpretation of emotional state; educate family members.

Swallowing and nutrition

Dysphagia is common in moderate-advanced Parkinson's; aspiration pneumonia is the leading cause of death. SALT swallowing assessment at first sign of difficulty — do not wait for obvious choking. Dietary modification: softened textures; thickened fluids; positioning during meals. Weight loss is common (dysphagia + hyperkinesis energy expenditure). Dietitian referral if weight loss >5% in 6 months.

Early SALT referral prevents aspiration pneumonia — the leading cause of death in Parkinson's

🧠

Advance Care Planning

While capacity intact; before cognitive decline

When to have the conversation

NICE NG71: advance care planning should be discussed early, before cognitive decline, and revisited at each review. Topics: preferred place of care and death (most want to die at home; Parkinson's often ends in hospital); DNACPR (Ian makes this decision now while he has capacity); ADRT (Advance Decision to Refuse Treatment); Lasting Power of Attorney — financial and health and welfare (especially important before PDD); organ donation.

Levodopa NBM planning

As part of advance care planning: document explicit instruction that if Ian is admitted to hospital and cannot swallow, his levodopa MUST NOT be stopped without alternative provision (NG tube medications or SC apomorphine infusion). This instruction, placed prominently in the medical record, prevents the commonest and most preventable hospital harm in advanced Parkinson's.

ACP prevents hospital harm; honours patient autonomy; protects against unwanted interventions

👨‍👩‍👧

Carer Support

Mary's wellbeing is clinical; carer burnout prevents patient harm

What Mary needs

Formal carer assessment (Social Services — legal right under Care Act 2014). Carer's Allowance eligibility (governs hours of caring). Parkinson's UK Carer Support Group. GP appointment for Mary separately — her own health (anxiety, depression, physical health) may have been neglected. Respite care options. Night-time care agency for when Ian's care needs increase.

ICD disclosure

If Ian is later prescribed a dopamine agonist: specifically warn Mary about ICD. Carers often detect ICD behaviour (gambling, changed sexual behaviour, excessive internet purchasing) before the patient discloses or before they recognise it themselves. Empower Mary: "If you notice significant changes in behaviour, please tell us — it is an important medication side effect."

Carer support is evidence-based for improved patient outcomes and delayed institutionalisation

7D — Parkinson's medications guide (specialist initiates — GP monitors)

Parkinson's medications are initiated and titrated by the specialist — the GP's role is to prescribe on shared care agreement, monitor for ICD and other side effects, manage the NBM crisis plan, and provide annual medication review. The most important GP-level pharmacology knowledge: (1) metoclopramide and prochlorperazine are absolutely contraindicated; (2) dopamine agonists carry a mandatory ICD warning; (3) levodopa cannot be safely stopped abruptly; (4) antipsychotics in Parkinson's are dangerous — only quetiapine or clozapine if absolutely required.

Motor fluctuation management

Wearing-off: duration of levodopa effect shortens; symptoms return predictably before next dose. Options: increased dose frequency; modified-release levodopa at bedtime; add COMT inhibitor (entacapone — extends levodopa effect); add MAO-B inhibitor (rasagiline — mild symptom benefit)
Peak-dose dyskinesias: involuntary movements at peak levodopa effect; reduce levodopa dose; add amantadine (anti-dyskinesia effect); specialist manages
Unpredictable off periods: rescue medication — apomorphine pen injection (SC); fast-acting sublingual apomorphine (Apo-go Pen)

Absolutely contraindicated in Parkinson's disease

Metoclopramide: dopamine D2 antagonist; causes acute severe motor deterioration; many GPs are unaware of this interaction — this is one of the most common avoidable drug errors in Parkinson's
Prochlorperazine (Stemetil): same mechanism; review and stop any Parkinson's patient currently prescribed this
Typical antipsychotics (haloperidol, chlorpromazine): severe deterioration; NMS risk
If antipsychotic absolutely required (psychosis): quetiapine (preferred) or clozapine only; specialist involvement mandatory
DLB: antipsychotics cause fatal neuroleptic sensitivity — absolute contraindication

7E — Medication selector

Select clinical scenario — see drug cards below

New diagnosis (specialist initiates) Young-onset Parkinson's (<60) Wearing-off / motor fluctuations Parkinson's disease dementia (PDD) ICD concern (dopamine agonist) NBM / cannot swallow (crisis)

Parkinson's medication guide (specialist initiates; GP monitors)

New diagnosis: levodopa/carbidopa (most effective; motor complications with long-term use) or dopamine agonist (young-onset; delay levodopa). Young-onset: dopamine agonist preferred (ropinirole, rotigotine patch) — delays levodopa motor complications; MANDATORY ICD warning. Wearing-off: add entacapone (COMT inhibitor) to extend levodopa effect; specialist decision. Parkinson's disease dementia: rivastigmine (ONLY licensed cholinesterase inhibitor for PDD). ICD on dopamine agonist: dose reduction or switch to levodopa urgently (specialist). NBM crisis: NG tube medications OR SC apomorphine infusion — urgent specialist/neurology; NEVER stop levodopa without alternative. Metoclopramide/prochlorperazine: ABSOLUTELY CONTRAINDICATED. Antipsychotics: ONLY quetiapine or clozapine if required (DLB: NONE).

7F — Drug reference cards

Levodopa/Carbidopa (Sinemet / Madopar)

Sinemet 62.5, 110, 275 tablets · Madopar 62.5, 125, 187.5 capsules · Most effective Parkinson's medication

✓ Most effective; gold standard; motor complications with long-term use

Gold standard motor controlStart 62.5–125mg TDS; titrate; specialist manages

✓ When to prefer

Most effective Parkinson's medication; "gold standard" for motor symptom control; first choice in older patients (>65) or those with cognitive impairment (dopamine agonists cause more neuropsychiatric side effects in elderly)

Carbidopa (or benserazide in Madopar) prevents peripheral conversion of levodopa to dopamine — reduces nausea and palpitations

Response to levodopa (≥30% improvement) is a diagnostic criterion supporting idiopathic Parkinson's disease

✗ Long-term motor complications

Wearing-off: levodopa effect shortens with disease progression — symptoms return before next dose. Typically develops within 5 years of initiating levodopa. Peak-dose dyskinesias: involuntary movements at peak levodopa effect. Manage by adjusting dose, frequency, and adding other agents — specialist decision. NEVER stop abruptly (akinetic crisis).

NBM crisis: if patient cannot swallow oral levodopa → acute off state → severe rigidity, hyperpyrexia, rhabdomyolysis. Plan: NG tube medications or subcutaneous apomorphine infusion. Document NBM plan in all Parkinson's patients' records.

⚠ Side effects

Nausea (early; usually resolves; domperidone if needed — NOT metoclopramide). Orthostatic hypotension. Dyskinesias (long-term). Hallucinations (long-term; dose-related). Impulse control disorders (less common than with dopamine agonists but can occur).

🔬 Monitor

Wearing-off pattern (seizure diary equivalent — "on/off diary"). Dyskinesias (video if possible for specialist review). Orthostatic hypotension (lying/standing BP). PHQ-9. MoCA annually. ICD screen at every review. Document NBM plan: "If nil by mouth — do not stop levodopa without NG tube or SC apomorphine plan — contact neurology."

💬 Counselling (NBM plan)

"There is one critical rule I need you and Mary to remember: if you are ever admitted to hospital or become unable to swallow for any reason — you must make sure the hospital doctors know that your Parkinson's medication must not just be stopped. If you cannot swallow it, they need to give it through a tube or by injection. Stopping it can cause a dangerous crisis. Please keep this written down and carry it with you."

Levodopa: gold standard for Parkinson's motor control. Long-term complications: wearing-off and dyskinesias — specialist manages. NBM rule: the most important safety issue in advanced Parkinson's — document the plan explicitly in every patient's record. NEVER use metoclopramide or prochlorperazine for levodopa-associated nausea — use domperidone instead.

Ropinirole (Requip / Requip XL)

Immediate release and XL extended release · Dopamine D2/D3 agonist · ICD mandatory warning

⚠ Dopamine agonist — ICD mandatory warning before prescribing

Dopamine agonist; young-onset preferredStart 0.25mg TDS (IR); titrate to effect; XL 2–8mg OD

✓ When to prefer

Young-onset Parkinson's (<60 years): dopamine agonists preferred to delay levodopa initiation — levodopa motor complications (wearing-off, dyskinesias) develop after 5 years; delaying levodopa initiation delays these complications

Monotherapy in early mild disease (older patients: prefer levodopa due to ICD risk)

Adjunct to levodopa for wearing-off (reduces off time)

⛔ Impulse Control Disorder — MANDATORY warning

Impulse Control Disorders (ICD) affect up to 17% of patients on dopamine agonists: gambling (most common), hypersexuality, binge eating, compulsive shopping. Can cause catastrophic financial and social harm. Must warn patient AND CARER before prescribing. Screen at EVERY review: "Have you noticed any changes in urges to gamble, shop, eat, or sexual behaviour?" If ICD detected: urgent dose reduction or switch to levodopa under specialist supervision.

Sudden-onset sleep (narcolepsy-like): occurs without warning; patient must not drive if this happens; specific DVLA warning required. Peripheral oedema. Nausea (early).

⚠ Side effects

ICD (see above — most important). Sudden-onset sleep. Nausea and orthostatic hypotension early. Hallucinations (more common than levodopa; elderly particularly vulnerable). Peripheral oedema. Dyskinesias (less than levodopa). Fibrotic reactions (rare — erythrocyte sedimentation, chest X-ray annually in high-dose long-term).

🔬 Monitor

ICD screen at EVERY review (patient AND carer asked separately if possible). Sudden-onset sleep — DVLA implications. Orthostatic hypotension. PHQ-9. MoCA. Peripheral oedema. Dyskinesias. ESR and CXR if very high dose long-term (fibrosis screening).

💬 Counselling (ICD warning)

"Before you start this medication, I need to tell you about an important side effect that affects a significant number of people. Some people on this type of medication notice changes in their behaviour — particularly urges to gamble, to spend money, to eat more than usual, or changes in sexual drive. These can happen gradually without you noticing at first. Please tell your family as well, because sometimes they notice before you do. If any of these things happen, even mildly, tell us immediately — we can adjust the medication."

Ropinirole: dopamine agonist; preferred in young-onset Parkinson's to delay levodopa. ICD warning is MANDATORY before prescribing — warn patient AND carer; screen at every review. Sudden-onset sleep: DVLA warning required — must not drive if this occurs. Elderly: higher ICD and neuropsychiatric risk — prefer levodopa in patients over 65–70. Specialist initiates; GP monitors ICD at every review.

Rasagiline (Azilect)

1mg tablet OD · MAO-B inhibitor · Mild symptomatic; possible neuroprotective (unproven)

✓ Mild symptomatic benefit; adjunct to levodopa

MAO-B inhibitor; adjunct1mg OD (no titration); as monotherapy or adjunct

✓ Appropriate for

Early Parkinson's disease: mild symptomatic benefit as monotherapy; may delay need for levodopa

Adjunct to levodopa: reduces wearing-off; comparable efficacy to entacapone for this indication

Simple dosing (once daily) — particularly useful in patients with complex regimes or compliance difficulties

✗ Drug interactions

Serotonin syndrome: MAO-B inhibitors + SSRIs/SNRIs/tramadol/pethidine/dextromethorphan — potentially fatal. NICE: can be used with caution with SSRIs but at lowest effective doses and with monitoring for serotonin syndrome symptoms (agitation, hyperthermia, myoclonus, tachycardia). Avoid pethidine entirely (contraindicated).

Tyramine interaction: selegiline (older MAO-B inhibitor) has significant tyramine (cheese) interaction; rasagiline has minimal tyramine interaction at standard doses — generally safer than selegiline in this respect.

⚠ Side effects

Generally well-tolerated. Headache (early). Flu-like symptoms. ICD possible (less common than dopamine agonists). May augment dyskinesias when combined with levodopa at high doses.

🔬 Monitor

Drug interaction screen at every prescription change (SSRIs/SNRIs — serotonin syndrome risk). ICD screen at annual review. Dyskinesias if on levodopa combination. Hepatic function (metabolised by CYP1A2).

💬 Counselling

"This medication has a significant interaction with some antidepressants and pain medicines. If your GP or any other doctor prescribes you a new medication, please tell them you are on rasagiline. And if you ever feel agitated, hot, and notice your muscles twitching — particularly after starting a new medication — seek urgent medical advice."

Rasagiline: MAO-B inhibitor; mild symptomatic benefit early Parkinson's; reduces wearing-off as levodopa adjunct. Critical interaction: SSRIs/SNRIs → serotonin syndrome (caution but not absolute contraindication). Pethidine: absolute contraindication. Selegiline (older MAO-B inhibitor) has tyramine dietary restriction; rasagiline generally safer in this respect at standard doses.

Entacapone (Comtess) / Stalevo (levodopa+carbidopa+entacapone)

200mg tablets with each levodopa dose · COMT inhibitor · Wearing-off management

✓ Wearing-off; extends levodopa duration

COMT inhibitor; wearing-off200mg with each levodopa dose (up to 10× daily)

✓ When to use

Wearing-off: extends levodopa effect by inhibiting COMT (catechol-O-methyltransferase) — peripheral enzyme that breaks down levodopa; inhibition prolongs levodopa plasma half-life

Stalevo (combination tablet) simplifies regimen when adding entacapone to established levodopa — improves compliance

✗ Cautions

Augments levodopa effects — may worsen dyskinesias if levodopa dose is high; specialist may need to reduce levodopa dose when adding entacapone. Diarrhoea (common, usually self-limiting). Urine discolouration (orange-brown — harmless; warn patient). Rare hepatotoxicity (tolcapone — a related COMT inhibitor — has more significant hepatotoxicity risk).

⚠ Side effects

Diarrhoea (up to 10%). Orange urine (harmless). Nausea. Augmented dyskinesias. Headache. Orthostatic hypotension.

🔬 Monitor

Dyskinesias on initiating entacapone (may need levodopa dose reduction). Diarrhoea resolution. "Off" diary — wearing-off duration reduction. LFTs if symptoms of liver toxicity.

💬 Counselling

"This tablet is taken with each levodopa dose to make the levodopa work for longer. You may notice your urine turns orange-brown — this is completely harmless and just how the medication works. If you develop persistent diarrhoea, let us know, as that is a recognised side effect."

Entacapone: COMT inhibitor added to levodopa for wearing-off; extends levodopa duration. Available as Stalevo combination tablet with levodopa and carbidopa. Orange urine discolouration — harmless but warn patient. Augments dyskinesias — specialist may reduce levodopa dose. Tolcapone (alternative COMT inhibitor) has hepatotoxicity monitoring requirements.

Rotigotine Transdermal Patch (Neupro)

2mg / 4mg / 6mg / 8mg / 12mg /24hr patches · Continuous dopaminergic stimulation · NBM alternative

✓ Transdermal dopamine agonist; useful in NBM or dysphagia

Dopamine agonist — transdermalStart 2mg/24hr; titrate by 2mg/week; max 16mg/24hr

✓ Advantages

Transdermal delivery: continuous dopaminergic stimulation (avoids peak-and-trough of oral medications); particularly useful in patients with dysphagia or who are NBM (patch continues to work when patient cannot take oral medications)

Once-daily application; improved compliance; no GI absorption issues

Can be used as monotherapy early Parkinson's or adjunct to levodopa

✗ ICD warning (same as all dopamine agonists)

Same ICD risk as oral dopamine agonists — mandatory warning before prescribing; screen at every review. Sudden-onset sleep: DVLA warning. Application site reactions (rotation protocol essential).

⚠ Side effects

Application site reactions (erythema, pruritus) — rotate sites; never reapply to same site within 14 days. ICD. Nausea. Somnolence. Hallucinations (less than oral agonists but possible). Orthostatic hypotension.

🔬 Monitor

ICD screen at every review. Application site assessment. DVLA sudden-onset sleep warning. Orthostatic BP. MoCA if elderly. MRI compatibility note: must remove patch before MRI (thermal burns otherwise).

💬 Counselling

"This patch goes on your skin and delivers the medication continuously through the day and night. Rotate the site each day — never put it on the same place twice in 14 days. Remove it before any MRI scan — and remind hospital staff too. The same warning applies as to all Parkinson's patches and tablets: watch for any changes in gambling, spending, eating, or sexual behaviour, and tell us straight away."

Rotigotine patch: transdermal dopamine agonist; same ICD warning as oral agonists — mandatory; continuous delivery avoids peak-and-trough; useful when patient cannot swallow (dysphagia, NBM) — patch continues working even when oral medications cannot be given. Remove before MRI (thermal burns). Rotate application sites (14-day gap before reuse).

Rivastigmine (Exelon)

1.5mg / 3mg / 4.5mg / 6mg capsules · 4.6mg/24hr and 9.5mg/24hr patches · Only licensed cholinesterase inhibitor for Parkinson's disease dementia

✓ Parkinson's disease dementia (PDD) — only licensed option

Parkinson's disease dementiaStart 1.5mg BD; increase every 2 weeks; max 6mg BD (oral); or patch 4.6mg/24hr → 9.5mg/24hr

✓ Specific indication

Parkinson's disease dementia (PDD): the ONLY cholinesterase inhibitor currently licensed specifically for PDD; modest but clinically meaningful improvement in cognition, daily function, and behavioural symptoms

Also licensed for Alzheimer's disease and Dementia with Lewy Bodies (DLB) — where it is often used for both cognitive symptoms and to reduce visual hallucinations

Patch formulation improves GI tolerability and compliance compared with capsules

✗ Cautions

May worsen Parkinson's tremor (cholinergic effect — antagonises dopaminergic motor improvement). GI side effects significant (nausea, vomiting, diarrhoea, weight loss) — particularly with capsules; patch has better GI tolerability. Bradycardia/syncope: caution in cardiac conduction disease. Must not use typical antipsychotics alongside if DLB — fatal neuroleptic sensitivity.

⚠ Side effects

Nausea and vomiting (common; start low, go slow; give with food; patch preferred). Diarrhoea. Weight loss. Tremor worsening. Bradycardia. Insomnia. Agitation.

🔬 Monitor

MoCA at 3 months and 6-monthly (efficacy assessment). Weight (GI side effects → weight loss). Heart rate and rhythm (bradycardia). Tremor (may worsen). GI side effects: if significant, switch to patch formulation. MMSE or MoCA trend — discontinue if no benefit after 3–6 months of adequate dose.

💬 Counselling (carer)

"This medication can help with the memory and thinking difficulties that sometimes come with Parkinson's disease. It works slowly, and the benefit is usually modest rather than dramatic. The most common side effects are nausea and stomach upset — giving it with food helps, and the patch version is gentler on the stomach if tablets cause problems. Please let us know if tremor worsens — sometimes this medication can temporarily make tremor a bit worse."

Rivastigmine: the ONLY licensed cholinesterase inhibitor for Parkinson's disease dementia (PDD) — donepezil and galantamine are not licensed for PDD though sometimes used off-label. DLB: rivastigmine also used and often very effective for visual hallucinations and fluctuating cognition. Note: when Parkinson's dementia is suspected, AVOID typical antipsychotics (DLB: fatal neuroleptic sensitivity). Tremor worsening is a recognised side effect.

7G — Psychosocial impact of Parkinson's disease

🫂

Parkinson's disease — progressive loss of autonomy, identity, and independence

Parkinson's disease is a lifelong progressive condition that touches every dimension of personhood. The tremor and rigidity are visible — but the non-motor features (depression, cognitive decline, loss of smell, sexual dysfunction, constipation, loss of voice, dysphagia) are often more disabling and less visible. Ian's first appointment is the beginning of a relationship between the GP, Ian, and Mary that will span years. Getting it right at the start — acknowledging the fear, providing accurate prognosis, addressing the practical issues (metoclopramide, DVLA) — builds the foundation for every consultation that follows.

🧠

Depression and Mental Health

Depression affects 35–45% of people with Parkinson's disease. It is not just a reactive response to diagnosis — the same neurodegeneration that causes motor symptoms also affects serotonergic and dopaminergic pathways involved in mood. PHQ-9 at every review. SSRIs (sertraline, citalopram) are evidence-based in Parkinson's depression. Levodopa and dopamine agonists may improve mood as a secondary effect. Referral to clinical psychology for CBT if appropriate.

"Living with Parkinson's can significantly affect mood — in fact, depression is extremely common with this condition and it is not just about feeling upset about the diagnosis. It is a neurological feature we can treat. I want to check your mood carefully at each appointment."

🎭

Identity and Role Loss

Ian was a teacher — an identity built around intellect, communication, and authority. Parkinson's threatens all three: micrographia (writing), hypophonia (voice), and potential cognitive decline (intellect). The psychological task of adapting to a changing sense of self is a major challenge. Psychological support, peer groups (Parkinson's UK), and creative expression (music, art) are meaningful interventions alongside medication.

"Adjusting to a condition that changes the way you move and communicate is really hard, especially when those things are central to your identity. Parkinson's UK has peer support groups where people share experiences — many people find them genuinely helpful, not just for information but for knowing you are not alone."

👨‍👩‍👧

Family and Relationships

Parkinson's disease redefines family relationships — particularly the spousal relationship. Mary is transitioning from wife to carer, often without acknowledgement or support. The ICD warning is family-level: carers must know to report changes in behaviour. Advance care planning decisions involve the family. Open communication between Ian, Mary, and the GP team is the foundation of good Parkinson's management.

"Mary, your observations are medically important — you notice things that Ian may not. If you ever notice significant changes in behaviour, or if Ian starts talking about gambling, spending, or other urges, please let us know immediately. It can be a side effect of the medication. You are an important part of Ian's medical team."

🔮

Prognosis and Hope

Median survival from diagnosis has increased significantly with modern treatment. Most patients live 10–20 years with Parkinson's. The disease course is highly variable. Many maintain excellent quality of life for years. The framing of prognosis matters enormously: honest about progression; emphasising what can be controlled (medication, exercise, lifestyle); naming what good treatment achieves; and connecting the patient with the community of people living well with Parkinson's.

"70% of people with Parkinson's achieve good motor control with medication, and many continue living active lives for many years. Exercise appears to slow the disease in some studies. We cannot predict your course exactly, but good treatment, good support, and staying active genuinely makes a difference."

7H — Follow-up

6 Weeks — Neurology Appointment

Neurologist/geriatrician with movement disorders expertise confirms or excludes Parkinson's diagnosis; advises on AED initiation; reviews metoclopramide washout progress; arranges DaTscan or MRI if indicated; DVLA letter for specialist medical report. GP follow-up 2 weeks after neurology appointment to discuss plan and begin shared care.

NICE NG71: 6 weeks from GP referral

3 Months — AED Initiation Review

If Parkinson's medication started: tolerability; motor improvement; ICD screen (patient AND Mary); DVLA status; orthostatic BP; PHQ-9; MoCA. If dopamine agonist started: ICD warning given and understood? Sudden-onset sleep discussion. Drug interactions reviewed. Falls assessment. Exercise plan discussed.

ICD screen: patient and carer both askedDopamine agonist: sudden-onset sleep DVLA warning

6 Months — Parkinson's Nurse Specialist Review

Parkinson's nurse specialist (PNS): medication titration between specialist appointments; community liaison; carer support; specialist nursing review. GP review: wearing-off pattern; dyskinesias; motor fluctuations; referral to specialist if significant change in motor function. Physiotherapy and OT referral if not yet done. SALT if speech or swallowing concerns.

Wearing-off developing: specialist referral for medication adjustment

Annual GP Parkinson's Review (NICE NG71 mandated)

Motor function; non-motor features (depression, cognitive, autonomic, sleep, pain); medication compliance; ICD screen; falls and fracture risk; MoCA; PHQ-9; lying/standing BP; DVLA status; advance care planning; carer wellbeing (Mary); community support; swallowing; weight; exercise adherence. Valproate PPP analogy: levodopa NBM plan documented and updated annually.

Annual: motor; non-motor; ICD; MoCA; PHQ-9; BP; DVLA; ACP; carer

7I — Monitoring

Annual GP Parkinson's review — NICE NG71 minimum standard

Motor function: disease progression; wearing-off pattern; dyskinesias; falls frequency; gait and balance (TUG). Non-motor features: PHQ-9 (depression 35–45%); MoCA (cognitive decline; PDD 30–40%); sleep (RBD; excessive daytime somnolence); pain; autonomic (lying/standing BP; urinary symptoms; constipation). ICD screen: mandatory at every review if on dopamine agonist — ask both patient and carer. Medication compliance: missed doses; understanding of NBM rule. Drug interactions: metoclopramide/prochlorperazine — check and remove if present; SSRIs + MAO-B inhibitor (serotonin syndrome risk). DVLA: current driving status; cognitive and motor safety update. Falls and fracture risk: TUG; FRAX; calcium and vitamin D; bisphosphonate. Carer wellbeing: Mary — depression screen; carer assessment update; respite needs. Advance care planning: DNACPR; preferred place of care; LPA; levodopa NBM plan.

7J — Safety-netting

⚠ Three essential safety-net rules for Parkinson's disease

Documentation requirements

Metoclopramide stopped: document date, reason ("suspected drug-induced parkinsonism"), alternative antiemetic prescribed

DVLA advice: document date, advice given ("must notify DVLA"), patient's response, DVLA notification plan

ICD warning: document that ICD warning was given to patient AND carer before dopamine agonist prescribing; screen documented at each review

NBM levodopa plan: document explicitly in record — "if patient admitted NBM: do not stop levodopa; NG tube medications or SC apomorphine; contact neurology"

Neurology referral: date, urgency, clinical information included, specific questions to specialist

Carer wellbeing: Mary's concerns addressed; carer assessment arranged; Parkinson's UK resources given

6 WeeksNeurology appointment; DVLA notified; metoclopramide washout progress

3 MonthsAED tolerability; ICD screen; MoCA; PHQ-9; falls

AnnualFull Parkinson's review per NICE NG71; ICD; NBM plan; carer; ACP

🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills

Closing the consultation

"The most important thing I am doing today is stopping the metoclopramide — it is the nausea tablet that can cause exactly these symptoms by blocking dopamine. I am replacing it with a safer one."

"I cannot diagnose Parkinson's disease today — only the specialist can. I am referring you urgently to a neurologist who specialises in this. That should happen within the next 6 weeks."

"On driving: you need to notify the DVLA. Parkinson's is a condition they need to know about. But it does not automatically mean you lose your licence — they assess each person individually, and many people with early Parkinson's continue driving for years."

"There is a very important safety rule for the future: if you are ever in hospital or unable to swallow, your Parkinson's medication must not be stopped without a substitute. Please carry that information with you."

"Mary — I want to make sure you are supported too. How are you managing? Can I arrange a carer assessment for you?"

"Is there anything else before we finish?"

Deductions

Metoclopramide not stopped — the most important immediate clinical action
Parkinson's diagnosed by GP — specialist must confirm
Levodopa or dopamine agonist started without specialist assessment
DVLA not discussed — mandatory and medico-legally important
ICD warning not given if dopamine agonist discussed
NBM levodopa crisis not mentioned
Mary's wellbeing not addressed

Tasks — key criteria

Metoclopramide stopped; alternative prescribed; reason explained
Specialist referral within 6 weeks (NICE NG71)
DVLA: notify; not automatic revocation; individual assessment
Non-motor features screened (mood, cognition, sleep)
ICD warning if dopamine agonist mentioned
NBM levodopa safety rule given

Relating to Others

Ian's fear acknowledged before clinical agenda
ICE all three; Mary addressed directly
DVLA empathetic and accurate
Prognosis honest and hopeful
Mary's carer role acknowledged; carer support offered
Closing question asked

🔴 Red

Metoclopramide not stopped; Parkinson's diagnosed; levodopa started; DVLA not mentioned; ICD warning absent; Mary ignored; NBM rule not given; non-motor features not asked

🟠 Amber

Metoclopramide stopped; neurology referred; DVLA mentioned vaguely; ICD warning absent; Mary not addressed; non-motor features partially explored; NBM rule not given; ICE partial

🟢 Green

Metoclopramide stopped with explanation; neurology 6 weeks; DVLA accurate; ICD warning if agonist; NBM rule given; Mary's carer role acknowledged; non-motor screened; ICE all three; exercise; falls assessment; ACP mentioned; closing question

"Hello, doctor. My wife made the appointment — she has been worried. I suppose I have been too, but I didn't want to make a fuss. I've been having this tremor in my right hand for about 9 months now, and things have been getting a bit slower. Mary's noticed more than I have, I think."

Who you are

Ian Hopkinson, 67, retired secondary school teacher of 35 years (English literature). Lives with wife Mary, 65. Two adult children, four grandchildren. Drives a 2019 Ford Focus — collects grandchildren from school weekly (15-mile round trip). Active: gardening, local walking group, crossword puzzles daily. Recently finds gardening tasks slower and crossword handwriting is "going small". Had a bout of nausea 3 months ago after antibiotics — GP prescribed metoclopramide; the nausea resolved but he has continued taking it daily because "it said to continue for nausea". He is quietly terrified about the diagnosis but has not said this to Mary or the GP. He suspects Parkinson's disease — his father had it. He has not told anyone about the driving fear because he thinks mentioning it might prompt the doctor to take his licence.

Hidden concerns (reveal only if ICE explored)

Primary hidden fear: "Is this Parkinson's disease?" — his father had Parkinson's and the last few years of his life were very difficult. Ian is frightened of losing his independence, becoming a burden to Mary, and following the same trajectory. Will only reveal this if asked "what do you think is causing this?" or "is there something specific you are worried about?"

Driving fear: He has not told the GP he still drives because he is afraid the GP will immediately take his licence away. If asked directly: "I still drive — I collect the grandchildren every week. It's important to me." If the GP explains that DVLA notification does not automatically mean licence loss: genuine relief.

Metoclopramide question: If given the opportunity, will ask at the end: "Could this have been caused by the tablets you gave me for the nausea?" — says this tentatively, not accusatorially. Responds very well if GP acknowledges this openly.

Mary: Mary has been watching Ian deteriorate for 9 months. She is worried and tired. If addressed directly, she will say: "I've noticed he doesn't swing his right arm when he walks anymore. And he takes forever to do up his buttons. It's been getting worse." She also noticed recently that he dropped a cup several times and "seemed startled" on waking — if asked about morning jerks: "Actually yes — he does sometimes jerk when he first wakes up."

Clinical details if asked

Tremor: right hand only; present when sitting with hand in lap; suppressed when he picks things up; returns when arm is held out. 4–6 Hz. Pill-rolling pattern described as "like rolling a small ball between my thumb and finger".
Handwriting: "starts normal and then gets smaller — by the end of the line it is tiny." Micrographia confirmed.
Gait: Mary confirms shuffling steps and absent right arm swing. Ian notices "I'm slower getting going."
Bradykinesia: dressing (buttons slow); turning over in bed; getting out of chair. Daily crossword puzzle significantly slower.
No falls. No freezing episodes. No early falls (important negative).
Non-motor: sleep — Mary mentions Ian "acts out his dreams" sometimes (kicks and shouts during sleep — RBD). Constipated for past 2 years. Lost sense of smell about 3 years ago (initially attributed to a cold). Mood slightly lower than usual but denies depression formally.
Medications: metoclopramide 10mg TDS (ongoing — should have been stopped); ramipril 5mg OD; atorvastatin 40mg OD. No prochlorperazine. No antipsychotics.
Family history: father had Parkinson's disease — diagnosed at 72, died at 81 from aspiration pneumonia.

Reactions and challenge

On the metoclopramide link: "I wondered about that. My wife looked it up online and found something, but I didn't want to say anything in case I was wrong." → responds very well to GP acknowledging the connection without defensiveness; profound relief if GP stops it voluntarily before Ian asks
On diagnosis: "So you don't know yet whether it is Parkinson's?" → accepts if GP explains why specialist needed; asks "how long will I wait?"
On DVLA: "Does that mean I lose my licence?" → responds well to "not automatically; DVLA assesses individually; many people with early Parkinson's continue driving" with genuine visible relief
On prognosis: "My father ended up very dependent. Is that what happens?" → responds well to honest, hopeful, individualised answer
Challenge line: "Could this have been caused by the tablets you gave me for the nausea?" (said tentatively, at end of consultation)

"Actually — I wanted to ask — could this have been caused by the tablets you gave me for the nausea? My wife looked it up and found something, but I wasn't sure."

Resolution: Ian and Mary will accept the consultation as satisfactory if the GP: (1) stops the metoclopramide openly and honestly, acknowledging the connection without being defensive; (2) explains why specialist diagnosis is needed and when; (3) gives accurate DVLA information without catastrophising (genuine relief that it is not automatic licence loss); (4) screens non-motor features including RBD, constipation, and smell; (5) addresses Mary directly as a carer; (6) gives ICD warning for the dopamine agonist discussion; (7) explains the NBM levodopa safety rule; (8) is honest but hopeful about prognosis; (9) asks closing question. They will disengage if: metoclopramide is not stopped; Parkinson's is diagnosed; levodopa is started; DVLA is not discussed; Mary is ignored.

🏥

Clinic Quick Reference

Parkinson's Disease — Clinical Decision Framework

NICE NG71 (2022) · Stop metoclopramide first · Specialist diagnoses · DVLA · ICD warning · NBM levodopa rule

▼expand

🚦 1 — Triage Algorithm

Suspected Parkinson's → Step 1: review ALL medications (stop metoclopramide/prochlorperazine) → Step 2: specialist referral within 6 weeks (NICE NG71) → DVLA → carer assessment — GP does NOT diagnose or start Parkinson's medication

↓

🔴 Emergency

Akinetic crisis (NBM, missed levodopa): NG tube / SC apomorphine + neurology urgent
Antipsychotic given to Parkinson's patient: NMS — ITU; stop antipsychotic
Severe ICD (large financial loss): urgent specialist; AED dose reduction
Sudden-onset sleep (driving accident): stop driving; urgent neurology

Emergency or same-day neurology

🟠 Urgent

New suspected Parkinson's: stop dopamine blockers; neurology within 6 weeks
Parkinson's plus features (early falls, rapid progression): neurology 2 weeks
ICD symptoms on dopamine agonist: specialist review; dose reduction

Stop metoclopramide; 6-week neurology referral

🟢 Annual Review

Stable Parkinson's: NICE NG71 annual GP review
Motor + non-motor; ICD screen; MoCA; PHQ-9; DVLA; ACP; carer

Annual NICE NG71 review; ICD screen; NBM plan

💊 2 — Prescribing Safety Rules

⛔ Absolutely Contraindicated in Parkinson's

Metoclopramide — dopamine antagonist; acute motor deterioration; very common error

Prochlorperazine (Stemetil) — same mechanism; review all elderly patients on this

Typical antipsychotics (haloperidol, chlorpromazine) — severe deterioration

DLB: ALL antipsychotics — fatal neuroleptic sensitivity reaction

Safe antiemetics: domperidone 10mg TDS or ondansetron 4–8mg

Safe antipsychotic if needed: quetiapine or clozapine only

ICD Warning — Mandatory Before Dopamine Agonist

Affects up to 17% of patients on dopamine agonists (ropinirole, pramipexole, rotigotine)

ICD types: gambling, hypersexuality, binge eating, compulsive shopping

Screen: ask patient AND carer at EVERY review — carers detect first

If ICD present: urgent specialist; dose reduction or switch to levodopa

Rasagiline + SSRIs: serotonin syndrome risk — caution; avoid pethidine

Metoclopramide ⛔

CONTRAINDICATED — most common preventable drug error in Parkinson's disease; also stop prochlorperazine

NICE NG71

Specialist diagnoses Parkinson's disease; GP refers within 6 weeks; GP does not start medication without specialist advice

ICD 17%

Dopamine agonists; gambling, hypersexuality, binge eating; mandatory warning; screen patient AND carer at every review

NBM rule

Cannot swallow levodopa = acute-off/akinetic crisis; NG tube or SC apomorphine; document plan in ALL patients' records

DVLA

Mandatory notification; individual assessment; dopamine agonist: sudden-onset sleep warning; cognitive impairment adds risk

30–40%

Parkinson's disease dementia (PDD) within 10 years; MoCA annually; rivastigmine only licensed CI for PDD

DLB ⛔

Antipsychotics cause fatal neuroleptic sensitivity; rivastigmine for cognitive symptoms; distinguish DLB from PD carefully

Annual review

NICE NG71 mandated: motor; non-motor; ICD; MoCA; PHQ-9; BP; DVLA; ACP; carer; NBM plan reviewed and updated

⚠ 3 — Safety-Netting

Follow-up timeline

6 weeks: Neurology; DVLA; metoclopramide washout; MoCA result

3 months: AED started; ICD screen; orthostatic BP; PHQ-9

Annual

Annual: NICE NG71 full review; ICD; MoCA; NBM plan; carer; ACP

📌 NBM levodopa plan + ICD screen + metoclopramide check at EVERY consultation

🚨 Red flags (Parkinson's plus): Early falls (<2 years) → PSP · Symmetrical onset → drug-induced/vascular · Early severe autonomic → MSA · Early dementia + hallucinations → DLB · Rapid progression → all Parkinson's plus · Poor levodopa response after 3 months → reconsider diagnosis

🛡️ Prescribing safety: Stop metoclopramide immediately · Stop prochlorperazine · Never typical antipsychotics · DLB: no antipsychotics (fatal) · Dopamine agonist: ICD warning mandatory · Rasagiline + SSRIs: caution (serotonin syndrome) · NBM plan in all records · Annual ICD screen: patient AND carer

🎓

SCA Exam Quick Reference

Parkinson's SCA — Metoclopramide · DVLA · ICD Warning · NBM Rule · Carer

Tasks · Relating to Others · Global Skills · RAG guide

▼expand

🕐 12-Minute Consultation Flow

0–1 min

Surface hidden fear + open ICE

"Something has been worrying you that you haven't said out loud — is there something specific you are frightened this might be?"

Ian has feared Parkinson's for 9 months. His father had it. Surface this before the clinical history or he sits through the whole consultation with unspoken terror.

Relating to OthersGlobal Skills

✗ Clinical interrogation first · ✗ Fear not explored · ✗ Mary ignored

1–5 min

Motor characterisation + medication review

"Tell me about the tremor — is it there when your hand is resting, or when you reach for something?" Then: "I want to look at all your medications very carefully — some common tablets can cause exactly what you are describing."

Resting tremor = Parkinson's. Action tremor = essential tremor. Identify metoclopramide. Non-motor screen: mood; sleep (RBD — Mary's observation of acting out dreams); constipation; smell.

TasksRelating to Others

✗ Not identifying metoclopramide as contraindicated · ✗ Not asking about resting vs action tremor · ✗ Non-motor features not asked

5–7 min

Stop metoclopramide + explain + DVLA

"Ian — the metoclopramide blocks dopamine and can cause exactly these symptoms. I am stopping it today. I am also referring you to a neurologist within 6 weeks. On driving — you must notify the DVLA. The diagnosis does not automatically mean you lose your licence."

TasksGlobal Skills

✗ Not stopping metoclopramide · ✗ Prescribing levodopa · ✗ Diagnosing Parkinson's · ✗ DVLA not mentioned

7–10 min

ICD warning + NBM rule + prognosis

"If the specialist prescribes a medication called a dopamine agonist, I want to warn you and Mary now: it can cause behaviour changes — urges to gamble or spend or changes in appetite or sexual behaviour. Watch for this and tell us immediately. And there is one rule for the future: if you are ever in hospital and cannot swallow, your Parkinson's medication must not be stopped without a substitute."

Mary addressed directly. Exercise prescription. Falls assessment. Carer assessment for Mary. Honest prognosis (hopeful, individualised, not catastrophic).

TasksRelating to Others

✗ ICD warning absent · ✗ NBM rule not given · ✗ Mary not addressed · ✗ Prognosis catastrophised

10–12 min

Plan + carer + close

"To summarise: metoclopramide stopped today; domperidone instead; neurologist within 6 weeks; DVLA notification; Parkinson's UK: 0808 800 0303. Mary — carer assessment arranged. Is there anything else for either of you?"

TasksGlobal Skills

✗ No carer support for Mary · ✗ No resources · ✗ No closing question to both

🔴🟠🟢 RAG — All 3 Domains

Tasks

🟢

Metoclopramide stopped + domperidone; NICE NG71 neurology; motor triad characterised; red flags screened; DVLA accurate; ICD patient+Mary; NBM rule; MoCA; non-motor; falls; exercise; carer assessment; ACP mentioned

🟠

Metoclopramide stopped; neurology referred; DVLA vague; ICD absent; NBM absent; Mary not addressed; motor triad partial; non-motor not asked; red flags absent

🔴

Metoclopramide not stopped; Parkinson's diagnosed; levodopa started; DVLA absent; ICD absent; Mary ignored; prochlorperazine prescribed as alternative

Relating to Others

🟢

Ian's fear surfaced first; ICE all three; metoclopramide challenge non-defensive; DVLA empathetic; ICD to both Ian and Mary; prognosis honest and hopeful; Mary carer role validated; NBM rule in plain language; closing question both

🟠

Warm; ICE partial; DVLA blunt; ICD warning absent; Mary not addressed; metoclopramide challenge defensively managed; prognosis vague

🔴

Clinical interrogation; Ian's fear ignored; DVLA absent; Mary invisible; metoclopramide challenge defensive; ICD absent; prognosis catastrophised or absent

Global Skills

🟢

GP role explained; metoclopramide stopped first; DVLA legal framing; ICD specific; NBM plain language; consultation structured around Ian and Mary's agenda; 12 minutes sufficient; both leave with clear plan

🟠

Adequate structure; DVLA given but not specific; ICD absent; NBM absent; ran over time; Mary sidelined

🔴

Fundamental errors (levodopa started; metoclopramide not stopped); DVLA absent; ICD absent; Mary ignored; plain language absent

💬 Key Phrases

💭 Metoclopramide link

"You are absolutely right to make that connection. Metoclopramide blocks dopamine in the brain and can cause exactly these symptoms. I am stopping it today and replacing it with a safer one. I want to be honest — it may not explain everything, but it is the right first step and I am glad you raised it."

😟 DVLA — driving preserved

"You must notify the DVLA — Parkinson's is a condition they need to know about. But I want to be clear: this does not automatically mean you lose your licence. They assess each person individually, and many people with early Parkinson's continue driving safely for years. I know collecting your grandchildren matters enormously to you."

🎯 ICD warning (patient+carer)

"Before the specialist prescribes a dopamine agonist, I want to tell you about a side effect that some people experience. It can cause changes in behaviour — particularly urges to gamble, spend money, eat excessively, or changes in sexual behaviour. Please watch for this. Mary — please watch too. If it happens, tell us immediately."

🔬 NBM levodopa rule

"There is one rule for the future that is really important. If you are ever admitted to hospital or cannot swallow for any reason, make sure the hospital doctors know that your Parkinson's medication must not just be stopped. They need to give it through a tube or by injection. Stopping it without an alternative can cause a dangerous crisis. Carry this written down."

📋 Prognosis (honest + hopeful)

"I know your father had Parkinson's, and I understand why you are frightened. The disease affects everyone differently — I cannot predict your course. What I can say is that treatment has improved significantly since then, that exercise makes a genuine difference, and that many people with Parkinson's live well and actively for many years."

💚 Mary acknowledged

"Mary — I want to make sure you are supported too. You have been watching Ian change for 9 months and carrying a lot. I would like to arrange a carer assessment, and I want you to know that Parkinson's UK has a helpline — 0808 800 0303 — and support groups for carers. Your wellbeing matters as much as Ian's."

🚫 8 Danger Zones

✗

Metoclopramide not stopped→ Most common preventable drug error in Parkinson's disease. Dopamine antagonist — causes acute motor deterioration. Stop immediately; prescribe domperidone or ondansetron instead. Document reason. Review ALL elderly patients on metoclopramide or prochlorperazine for this interaction.

✗

Parkinson's diagnosed by GP→ NICE NG71: specialist diagnosis mandatory. Many conditions mimic Parkinson's (drug-induced, essential tremor, PSP, MSA). Starting treatment on a wrong diagnosis is harmful. "I cannot diagnose Parkinson's today — the specialist will confirm after the metoclopramide has been stopped and washed out."

✗

Levodopa or dopamine agonist started in primary care→ Specialist-only initiation. The specialist chooses the AED based on syndrome, age, sex, and patient preference. Starting the wrong drug or at the wrong dose before diagnosis is confirmed causes harm. This is a major prescribing error.

✗

Prochlorperazine prescribed as "safer" alternative to metoclopramide→ Prochlorperazine is equally contraindicated — also a dopamine antagonist. The safe antiemetic alternatives are domperidone (first choice) and ondansetron. Never prescribe any phenothiazine antiemetic in suspected or confirmed Parkinson's disease.

✗

ICD warning not given before dopamine agonist→ ICDs affect up to 17% of patients on dopamine agonists. Patients lose life savings, marriages, and careers before detection. Mandatory warning to patient AND carer before prescribing; screen patient AND carer at every review. Carer often detects before patient acknowledges.

✗

NBM levodopa crisis not mentioned→ Akinetic crisis from levodopa withdrawal is one of the most common preventable hospital deaths in Parkinson's disease. Document the plan prominently in the patient's medical record. Give patient and carer a written instruction to show any admitting team. This saves lives.

✗

Mary not addressed as a patient in her own right→ Unpaid carers of Parkinson's patients have higher rates of depression, anxiety, and physical illness than the general population. Their wellbeing directly affects patient outcomes. Ask Mary directly; offer carer assessment; offer separate GP appointment; signpost Parkinson's UK Carer Support.

✗

DVLA advice catastrophised — "you will lose your licence"→ Parkinson's disease does not automatically revoke a driving licence. The DVLA assesses individually. Many patients with early, well-controlled Parkinson's continue driving for years with annual DVLA review. Catastrophising causes unnecessary distress and may reduce trust in the GP-patient relationship at the outset.

💊 Drug Quick-Pick by Scenario

New diagnosis >65 years (or cognitive impairment)

→Levodopa/carbidopa (Sinemet)

Most effective; fewer neuropsychiatric side effects than agonists in elderly

New diagnosis <60 years (young-onset)

→Dopamine agonist (ropinirole / rotigotine)

Delays levodopa motor complications; ICD mandatory warning

Wearing-off (duration shortening)

→Entacapone (COMT inhibitor)

Extends levodopa effect; may worsen dyskinesias — specialist adjusts dose

Parkinson's disease dementia (PDD)

→Rivastigmine (only licensed CI for PDD)

Donepezil not licensed for PDD; rivastigmine patch preferred (GI tolerability)

Nausea in Parkinson's patient

→Domperidone 10mg TDS or Ondansetron

⛔ NEVER metoclopramide or prochlorperazine

NBM / cannot swallow levodopa

→NG tube medications or SC apomorphine

Emergency; contact neurology; document plan in ALL patients' records

⛔ Metoclopramide and prochlorperazine ABSOLUTELY CONTRAINDICATED in Parkinson's disease · Levodopa: specialist initiates only per NICE NG71 · ICD warning MANDATORY before prescribing ANY dopamine agonist · Dopamine agonist sudden-onset sleep: DVLA warning; must not drive if this occurs · Rasagiline + SSRIs: serotonin syndrome risk; avoid pethidine · Antipsychotics: ONLY quetiapine or clozapine if required; DLB = NONE (fatal) · Rivastigmine: only licensed cholinesterase inhibitor for PDD · NBM levodopa plan: document prominently in ALL Parkinson's patients' records

Parkinson's Disease · GP Clinical Reasoning Framework v2 · NICE NG71 — Parkinson's disease in adults (2017, updated 2022) · NICE CKS Parkinson's disease (2024) · MHRA Drug Safety Update — Metoclopramide · DVLA Assessing Fitness to Drive (2023) · Parkinson's UK Clinical Guidelines

NICE NG71: GP does not diagnose Parkinson's disease or initiate medication — specialist within 6 weeks · Metoclopramide CONTRAINDICATED — most common preventable drug error in Parkinson's disease; also prochlorperazine; safe alternatives: domperidone, ondansetron · Dopamine agonist ICD mandatory warning: up to 17% affected; patient AND carer warned and screened at every review · Levodopa NBM rule: cannot swallow → akinetic crisis → NG tube or SC apomorphine; document in all patients' records · Annual NICE NG71 review: motor; non-motor (PHQ-9; MoCA; RBD; autonomic); ICD; DVLA; carer; ACP; NBM plan · Rivastigmine: only licensed cholinesterase inhibitor for Parkinson's disease dementia · DLB: antipsychotics fatal — neuroleptic sensitivity; rivastigmine for cognitive symptoms · DVLA: mandatory notification; individual assessment; most early Parkinson's continue driving; dopamine agonist sudden-onset sleep: specific driving warning

Teaching clinicians why each step matters — not just what to do · Always consult current NICE NG71, BNF, and DVLA fitness-to-drive guidance · Parkinson's UK helpline for patients and carers: 0808 800 0303 · Clinical judgement takes precedence over any framework

Parkinson's Disease

Red Flags — features that indicate NOT idiopathic Parkinson's disease

Safeguarding Considerations in Parkinson's Disease

🚗 DVLA and Road Safety

🏠 Falls and Home Safety

👨‍👩‍👧 Carer Burden and Wellbeing

💊 Prescribing Safety

🚗 Driving and Independence

🏥 Prognosis and the Fear of End-Stage Disease

👨‍👩‍👧 Mary's Experience as Carer

🎭 Loss of Identity and Role

💊 The Metoclopramide Question

🧠 Cognitive Change and Future Planning

999 / A&E Now

Within 1–6 Weeks

GP-Led with Specialist Support

Metoclopramide (Ian's case)

Prochlorperazine

Antipsychotics

PSP

MSA

DLB

Essential Tremor

Acknowledge the fear — it is real and legitimate

What the GP can do today

What cannot happen today

Select clinical scenario — see drug cards below

Depression and Mental Health

Identity and Role Loss

Family and Relationships

Prognosis and Hope

6 Weeks — Neurology Appointment

3 Months — AED Initiation Review

6 Months — Parkinson's Nurse Specialist Review

Annual GP Parkinson's Review (NICE NG71 mandated)

Annual GP Parkinson's review — NICE NG71 minimum standard

⚠ Three essential safety-net rules for Parkinson's disease

Documentation requirements

🎭 Patient actor brief — click to practise

Who you are

Hidden concerns (reveal only if ICE explored)

Clinical details if asked

Reactions and challenge